Title,Authors,Platform,Cited_url,Cited_count,Year
Progress and problems with the use of viral vectors for gene therapy,"CE Thomas, A Ehrhardt, MA Kay","Nature Reviews Genetics 4 (5), 346",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2876262014187779420,2405,2003
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways,"D Grimm, KL Streetz, CL Jopling, TA Storm, K Pandey, CR Davis, ...","Nature 441 (7092), 537","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=371540726176161461,8183465819785425214",1781,2006
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response,"CS Manno, GF Pierce, VR Arruda, B Glader, M Ragni, JJE Rasko, ...","Nature medicine 12 (3), 342",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15880124116564942717,1692,2006
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics,"MA Kay, JC Glorioso, L Naldini","Nature medicine 7 (1), 33",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5899369224939778345,1519,2001
Gene expression: RNA interference in adult mice,"AP McCaffrey, L Meuse, TTT Pham, DS Conklin, GJ Hannon, MA Kay","Nature 418 (6893), 38","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17832386419204329460,14588825238593946822,4735519295313856582",1509,2002
Adenovirus-associated virus vector–mediated gene transfer in hemophilia B,"AC Nathwani, EGD Tuddenham, S Rangarajan, C Rosales, J McIntosh, ...","New England Journal of Medicine 365 (25), 2357-2365",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6347142964872244403,1422,2011
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector,"MA Kay, CS Manno, MV Ragni, PJ Larson, LB Couto, A McClelland, ...","Nature genetics 24 (3), 257",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9624635025279460302,1194,2000
Inhibition of hepatitis B virus in mice by RNA interference,"AP McCaffrey, H Nakai, K Pandey, Z Huang, FH Salazar, H Xu, ...","Nature biotechnology 21 (6), 639",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4487723980093314622,897,2003
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B,"CS Manno, AJ Chew, S Hutchison, PJ Larson, RW Herzog, VR Arruda, ...","Blood 101 (8), 2963-2972",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6331157564515091778,784,2003
A nonviral minicircle vector for deriving human iPS cells,"F Jia, KD Wilson, N Sun, DM Gupta, M Huang, Z Li, NJ Panetta, ZY Chen, ...","Nature methods 7 (3), 197",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4494813974538414699,780,2010
Sarcoma derived from cultured mesenchymal stem cells,"J Tolar, AJ Nauta, MJ Osborn, A Panoskaltsis Mortari, RT McElmurry, ...","Stem cells 25 (2), 371-379",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1500399727224514639,706,2007
Long-term safety and efficacy of factor IX gene therapy in hemophilia B,"AC Nathwani, UM Reiss, EGD Tuddenham, C Rosales, P Chowdary, ...","New England Journal of Medicine 371 (21), 1994-2004",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15919642253259839781,690,2014
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors,"RO Snyder, CH Miao, GA Patijn, SK Spratt, O Danos, D Nagy, AM Gown, ...","Nature genetics 16 (3), 270",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6553733856567464101,681,1997
In vivo activity of nuclease-resistant siRNAs,"JM Layzer, AP McCaffrey, AK Tanner, ZAN Huang, MA Kay, BA Sullenger","Rna 10 (5), 766-771",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3542979144765139916,622,2004
State-of-the-art gene-based therapies: the road ahead,MA Kay,"Nature Reviews Genetics 12 (5), 316",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9561674620739030144,611,2011
Robust expansion of human hepatocytes in ,"H Azuma, N Paulk, A Ranade, C Dorrell, M Al-Dhalimy, E Ellis, S Strom, ...","Nature biotechnology 25 (8), 903",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9572515383416207145,589,2007
Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system,"SR Yant, L Meuse, W Chiu, Z Ivics, Z Izsvak, MA Kay","Nature genetics 25 (1), 35",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12141361745020089562,559,2000
Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8,"K Inagaki, S Fuess, TA Storm, GA Gibson, CF Mctiernan, MA Kay, H Nakai","Molecular Therapy 14 (1), 45-53",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3854537686376013844,558,2006
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors,"RO Snyder, C Miao, L Meuse, J Tubb, BA Donahue, HF Lin, DW Stafford, ...","Nature medicine 5 (1), 64",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5118424134976786713,517,1999
Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo,"ZY Chen, CY He, A Ehrhardt, MA Kay","Molecular therapy 8 (3), 495-500",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17413301930397054672,483,2003
Human tRNA-derived small RNAs in the global regulation of RNA silencing,"D Haussecker, Y Huang, A Lau, P Parameswaran, AZ Fire, MA Kay","Rna 16 (4), 673-695",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12432608796986981252,457,2010
The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.,"A Lieber, CY He, L Meuse, D Schowalter, I Kirillova, B Winther, MA Kay","Journal of virology 71 (11), 8798-8807",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13890068396340524728,446,1997
Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo,"H Nakai, SR Yant, TA Storm, S Fuess, L Meuse, MA Kay","Journal of virology 75 (15), 6969-6976",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15584850161708277546,430,2001
"The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9","B Akache, D Grimm, K Pandey, SR Yant, H Xu, MA Kay","Journal of virology 80 (19), 9831-9836",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13016521161643382895,415,2006
In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses,"D Grimm, JS Lee, L Wang, T Desai, B Akache, TA Storm, MA Kay","Journal of virology 82 (12), 5887-5911",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12204024535584226842,399,2008
Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method,"H Mizuguchi, MA Kay1","Human gene therapy 9 (17), 2577-2583",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16341560548307306232,391,1998
AAV serotype 2 vectors preferentially integrate into active genes in mice,"H Nakai, E Montini, S Fuess, TA Storm, M Grompe, MA Kay","Nature genetics 34 (3), 297",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17753038372154632242,384,2003
From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy,"D Grimm, MA Kay","Current gene therapy 3 (4), 281-304",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12798908298914383360,374,2003
Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors,"CE Thomas, TA Storm, Z Huang, MA Kay","Journal of virology 78 (6), 3110-3122",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7668249943081051291,371,2004
Biological basis for restriction of microRNA targets to the 3′ untranslated region in mammalian mRNAs,"S Gu, L Jin, F Zhang, P Sarnow, MA Kay","Nature structural & molecular biology 16 (2), 144",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4367418148589923719,364,2009
In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs,"MA Kay, S Rothenberg, CN Landen, DA Bellinger, F Leland, C Toman, ...","Science 262 (5130), 117-119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17058218589218142042,359,1993
Assessment of recombinant adenoviral vectors for hepatic gene therapy,"Q Li, MA Kay, M Finegold, LD Stratford-Perricaudet, SLC Woo","Human gene therapy 4 (4), 403-409",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9870356373869562052,349,1993
Site-specific genomic integration produces therapeutic Factor IX levels in mice,"EC Olivares, RP Hollis, TW Chalberg, L Meuse, MA Kay, MP Calos","Nature biotechnology 20 (11), 1124",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17909780484318261404,341,2002
High-resolution genome-wide mapping of transposon integration in mammals,"SR Yant, X Wu, Y Huang, B Garrison, SM Burgess, MA Kay","Molecular and cellular biology 25 (6), 2085-2094",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15739381071596232679,337,2005
Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration,"Y Malato, S Naqvi, N Schürmann, R Ng, B Wang, J Zape, MA Kay, ...","The Journal of clinical investigation 121 (12), 4850-4860",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7187445572331346634,322,2011
"Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6","D Grimm, MA Kay, JA Kleinschmidt","Molecular Therapy 7 (6), 839-850",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10863230066200751840,321,2003
Long–term hepatic adenovirus–mediated gene expression in mice following CTLA 4Ig administration,"MA Kay, AX Holterman, L Meuse, A Gown, HD Ochs, PS Linsley, ...","Nature genetics 11 (2), 191",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16594050144253323643,316,1995
Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice,"H Nakai, S Fuess, TA Storm, S Muramatsu, Y Nara, MA Kay","Journal of virology 79 (1), 214-224",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12180366569211594368,315,2005
Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk,"D Vollrath, W Feng, JL Duncan, D Yasumura, PM D'Cruz, A Chappelow, ...","Proceedings of the National Academy of Sciences 98 (22), 12584-12589",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17391466597526188876,294,2001
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs,"MA Kay, CN Landen, SR Rothenberg, LA Taylor, F Leland, S Wiehle, ...","Proceedings of the National Academy of Sciences 91 (6), 2353-2357",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7770967855676501240,292,1994
Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in …,"A Lieber, C He, I Kirillova, MA Kay","Journal of virology 70 (12), 8944-8960",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15130293557687535517,283,1996
A simple method for constructing E1-and E1/E4-deleted recombinant adenoviral vectors,"H Mizuguchi, MA Kay","Human gene therapy 10 (12), 2013-2017",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16764525317108976240,271,1999
"Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro","CH Miao, K Ohashi, GA Patijn, L Meuse, X Ye, AR Thompson, MA Kay","Molecular Therapy 1 (6), 522-532",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14261586394506083774,266,2000
Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains.,"D Barr, J Tubb, D Ferguson, A Scaria, A Lieber, C Wilson, J Perkins, ...","Gene therapy 2 (2), 151-155",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12531834246675482266,264,1995
Efficient lentiviral transduction of liver requires cell cycling ,"F Park, K Ohashi, W Chiu, L Naldini, MA Kay","Nature genetics 24 (1), 49",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15930467173395848291,263,2000
Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes,"MA Kay, P Baley, S Rothenberg, F Leland, L Fleming, KP Ponder, T Liu, ...","Proceedings of the National Academy of Sciences 89 (1), 89-93",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2359323377778796487,259,1992
A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob,"H Mizuguchi, N Koizumi, T Hosono, N Utoguchi, Y Watanabe, MA Kay, ...","Gene therapy 8 (9), 730",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2365995290117807998,243,2001
Silencing of episomal transgene expression by plasmid bacterial DNA elements ,"ZY Chen, CY He, L Meuse, MA Kay","Gene therapy 11 (10), 856",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17976845799733471841,242,2004
Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic,"JC Giering, D Grimm, TA Storm, MA Kay","Molecular therapy 16 (9), 1630-1636",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15627342192158481734,240,2008
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?,"D Grimm, MA Kay","The Journal of clinical investigation 117 (12), 3633-3641",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17980337562540177209,236,2007
A robust system for production of minicircle DNA vectors,"MA Kay, CY He, ZY Chen","Nature biotechnology 28 (12), 1287",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9311205548541586246,234,2010
Selection and evaluation of clinically relevant AAV variants in a xenograft liver model,"L Lisowski, AP Dane, K Chu, Y Zhang, SC Cunningham, EM Wilson, ...","Nature 506 (7488), 382",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6782912923475951639,231,2014
Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems,"P Parameswaran, E Sklan, C Wilkins, T Burgon, MA Samuel, R Lu, ...","PLoS pathogens 6 (2), e1000764",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14700894602308059553,229,2010
Transposition from a gutless adeno-transposon vector stabilizes transgene expression ,"SR Yant, A Ehrhardt, JG Mikkelsen, L Meuse, T Pham, MA Kay","Nature biotechnology 20 (10), 999",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6742529489567314081,226,2002
Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo,"ZY Chen, CY He, MA Kay","Human gene therapy 16 (1), 126-131",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13783569571403554376,223,2005
Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells,"T Deuse, M Stubbendorff, K Tang-Quan, N Phillips, MA Kay, T Eiermann, ...","Cell transplantation 20 (5), 655-667",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3741203222334628686,222,2011
Hepatic gene therapy: persistent expression of human α1-antitrypsin in mice after direct gene delivery in vivo,"MA Kay, Q Li, TJ Liu, F Leland, C Toman, M Finegold, SLC Woo","Human gene therapy 3 (6), 641-647",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4122008487399328569,221,1992
The loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo,"S Gu, L Jin, Y Zhang, Y Huang, F Zhang, PN Valdmanis, MA Kay","Cell 151 (4), 900-911",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14950599478927792113,218,2012
Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy,"D Grimm, S Zhou, H Nakai, CE Thomas, TA Storm, S Fuess, T Matsushita, ...","Blood 102 (7), 2412-2419",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11249165553120213140,209,2003
"Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver","D Grimm, L Wang, JS Lee, N Schürmann, S Gu, K Börner, TA Storm, ...","The Journal of clinical investigation 120 (9), 3106-3119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17263144371578580615,207,2010
Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors,"H Nakai, TA Storm, MA Kay","Nature biotechnology 18 (5), 527",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13410463694504102341,206,2000
The kinetics of rAAV integration in the liver,"CH Miao, RO Snyder, DB Schowalter, GA Patijn, B Donahue, B Winther, ...","Nature genetics 19 (1), 13",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17566632470025687768,206,1998
Therapeutic levels of human factor VIII and IX using HIV-1–based lentiviral vectors in mouse liver,"F Park, K Ohashi, MA Kay","Blood 96 (3), 1173-1176",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16451974271319302915,199,2000
Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver,"ZY Chen, SR Yant, CY He, L Meuse, S Shen, MA Kay","Molecular Therapy 3 (3), 403-410",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6591097643255455316,198,2001
Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo,"H Nakai, TA Storm, MA Kay","Journal of virology 74 (20), 9451-9463",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14819791492021675790,196,2000
Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver,"MA Kay, L Meuse, AM Gown, P Linsley, D Hollenbaugh, A Aruffo, ...","Proceedings of the National Academy of Sciences 94 (9), 4686-4691",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6793828536640309996,195,1997
Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex,"RJ Cristiano, LC Smith, MA Kay, BR Brinkley, SL Woo","Proceedings of the National Academy of Sciences 90 (24), 11548-11552",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3852988242483989154,195,1993
Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver,"H Nakai, Y Iwaki, MA Kay, LB Couto","Journal of Virology 73 (7), 5438-5447",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12037003895323816338,194,1999
Sustained survival of human hepatocytes in mice: A model for ,"K Ohashi, PL Marion, H Nakai, L Meuse, JM Cullen, BB Bordier, ...","Nature medicine 6 (3), 327",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13532940627287298769,193,2000
Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver,"H Nakai, X Wu, S Fuess, TA Storm, D Munroe, E Montini, SM Burgess, ...","Journal of virology 79 (6), 3606-3614",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13747062144493873565,186,2005
In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus,"BB Bordier, J Ohkanda, P Liu, SY Lee, FH Salazar, PL Marion, K Ohashi, ...","The Journal of clinical investigation 112 (3), 407-414",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=997037563511889136,186,2003
Hepatocyte transplantation: clinical and experimental application,"K Ohashi, F Park, MA Kay","Journal of molecular medicine 79 (11), 617-630",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7614265984708769993,181,2001
Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD.,"CE Murry, MA Kay, T Bartosek, SD Hauschka, SM Schwartz","The Journal of clinical investigation 98 (10), 2209-2217",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12552961162805315214,181,1996
Mechanisms of Hypoxia-induced Endothelial Cell Death ROLE OF p53 IN APOPTOSIS,"A Stempien-Otero, A Karsan, CJ Cornejo, H Xiang, T Eunson, ...","Journal of Biological Chemistry 274 (12), 8039-8045",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8070877419568942682,178,1999
Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors,"KH Narsinh, F Jia, RC Robbins, MA Kay, MT Longaker, JC Wu","nature protocols 6 (1), 78",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=164476958803600406,175,2011
Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells,"SR Yant, J Park, Y Huang, JG Mikkelsen, MA Kay","Molecular and cellular biology 24 (20), 9239-9247",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14893826554684297509,167,2004
Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males,"VR Arruda, PA Fields, R Milner, L Wainwright, MP De Miguel, PJ Donovan, ...","Molecular Therapy 4 (6), 586-592",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11574007593482214516,167,2001
Helper-independent Sleeping Beauty transposon–transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo,"JG Mikkelsen, SR Yant, L Meuse, Z Huang, H Xu, MA Kay","Molecular Therapy 8 (4), 654-665",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17619949159581034831,165,2003
Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors.,"K Brand, W Arnold, T Bartels, A Lieber, MA Kay, M Strauss, B Dörken","Cancer gene therapy 4 (1), 9-16",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8242150155047066006,157,1997
Distinct pathways of genomic progression to benign and malignant tumors of the liver,"AD Tward, KD Jones, S Yant, ST Cheung, ST Fan, X Chen, MA Kay, ...","Proceedings of the National Academy of Sciences 104 (37), 14771-14776",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3305306512367346422,155,2007
In vivo correction of murine tyrosinemia type I by DNA-mediated transposition,"E Montini, PK Held, M Noll, N Morcinek, M Al-Dhalimy, M Finegold, ...","Molecular Therapy 6 (6), 759-769",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17678796419456027767,155,2002
Combinatorial RNAi: a winning strategy for the race against evolving targets?,"D Grimm, MA Kay","Molecular Therapy 15 (5), 878-888",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=144446745575214778,154,2007
Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer,"S Ortiz-Urda, Q Lin, SR Yant, D Keene, MA Kay, PA Khavari","Gene therapy 10 (13), 1099",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5893109464770165518,154,2003
A new adenoviral helper–dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo,"A Ehrhardt, MA Kay","Blood 99 (11), 3923-3930",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18306359066112061193,152,2002
Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation,"ZY Chen, E Riu, CY He, H Xu, MA Kay","Molecular Therapy 16 (3), 548-556",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17883254589198485817,150,2008
Site-directed transposon integration in human cells,"SR Yant, Y Huang, B Akache, MA Kay","Nucleic acids research 35 (7), e50",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14476152126509884397,148,2007
Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction,"CH Miao, H Nakai, AR Thompson, TA Storm, W Chiu, RO Snyder, MA Kay","Journal of virology 74 (8), 3793-3803",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16950551410252453846,147,2000
Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo,"E Riu, ZY Chen, H Xu, CY He, MA Kay","Molecular Therapy 15 (7), 1348-1355",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12033580513656174059,144,2007
Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases,"K Ohashi, JM Waugh, MD Dake, T Yokoyama, H Kuge, Y Nakajima, ...","Hepatology 41 (1), 132-140",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3505126984359666876,143,2005
Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression,"B Fang, RC Eisensmith, H Wang, MA Kay, RE Cross, CN Landen, ...","Human gene therapy 6 (8), 1039-1044",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9959363306227768708,143,1995
How do miRNAs mediate translational repression?,"S Gu, MA Kay","Silence 1 (1), 11",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10530795528956726732,139,2010
Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors …,"ML Liu, BL Winther, MA Kay","Journal of virology 70 (4), 2497-2502",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17036070997576485046,138,1996
Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa,"V Sebastiano, HH Zhen, B Haddad, E Bashkirova, SP Melo, P Wang, ...","Science translational medicine 6 (264), 264ra163-264ra163",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13298150135540636472,136,2014
Promoterless gene targeting without nucleases ameliorates haemophilia B in mice,"A Barzel, NK Paulk, Y Shi, Y Huang, K Chu, F Zhang, PN Valdmanis, ...","Nature 517 (7534), 360",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5345831264950524730,135,2015
FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase,"A Falcon, H Doege, A Fluitt, B Tsang, N Watson, MA Kay, A Stahl","American Journal of Physiology-Endocrinology and Metabolism 299 (3), E384-E393",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10616251399240168292,134,2010
Adeno-associated virus vectors and hematology,"DW Russell, MA Kay","Blood, The Journal of the American Society of Hematology 94 (3), 864-874",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5807780333303145607,130,1999
Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes.,"A Lieber, CY He, SJ Polyak, DR Gretch, D Barr, MA Kay","Journal of virology 70 (12), 8782-8791",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16256921160082311659,130,1996
Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver,"AY Wang, A Ehrhardt, H Xu, MA Kay","Molecular Therapy 15 (2), 255-263",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=939517935593633046,126,2007
Targeted tumor killing via an intracellular antibody against erbB-2.,"J Deshane, GP Siegal, RD Alvarez, MH Wang, M Feng, G Cabrera, T Liu, ...","The Journal of clinical investigation 96 (6), 2980-2989",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8254807879892106640,125,1995
Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo,"F Park, MA Kay","Molecular therapy 4 (3), 164-173",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13348100596474054757,123,2001
Hepatocyte growth factor induces hepatocyte proliferation ,"GA Patijn, A Lieber, DB Schowalter, R Schwall, MA Kay","Hepatology 28 (3), 707-716",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2108227604908365999,123,1998
Gene therapy for metabolic diseases,"MA Kay, SLC Woo","ILAR Journal 36 (3-4), 47-53",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10345376096273798832,123,1994
Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia,"H Doege, D Grimm, A Falcon, B Tsang, TA Storm, H Xu, AM Ortegon, ...","Journal of Biological Chemistry 283 (32), 22186-22192",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1362750495273761760,122,2008
Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo,"AY Wang, PD Peng, A Ehrhardt, TA Storm, MA Kay","Human gene therapy 15 (4), 405-413",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14050960222314050107,122,2004
RNAi and gene therapy: a mutual attraction,"D Grimm, MA Kay","ASH education program book 2007 (1), 473-481",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11900969892324456070,120,2007
"The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver","AP McCaffrey, P Fawcett, H Nakai, RL McCaffrey, A Ehrhardt, TTT Pham, ...","Molecular Therapy 16 (5), 931-941",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13808461464271166413,117,2008
A prenylation inhibitor prevents production of infectious hepatitis delta virus particles,"BB Bordier, PL Marion, K Ohashi, MA Kay, HB Greenberg, JL Casey, ...","Journal of virology 76 (20), 10465-10472",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12162968639744360916,113,2002
Integrating adenovirus–adeno-associated virus hybrid vectors devoid of all viral genes,"A Lieber, DS Steinwaerder, CA Carlson, MA Kay","Journal of virology 73 (11), 9314-9324",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12369779488952230313,113,1999
Therapeutic serum concentrations of human alpha-1 antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes,"MA Kay, F Graham, F Leland, SLC Woo","Hepatology 21 (3), 815-819",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15514568924154340822,113,1995
MicroRNAs in ovarian carcinomas,"N Dahiya, PJ Morin","Endocrine-related cancer 17 (1), F77-F89",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11231130398423460288,112,2010
"Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice","AP McCaffrey, K Ohashi, L Meuse, S Shen, AM Lancaster, PJ Lukavsky, ...","Molecular Therapy 5 (6), 676-684",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11300594101311463226,112,2002
"Epstein–Barr virus/human vector provides high-level, long-term expression of α1-antitrypsin in mice","SM Stoll, CR Sclimenti, EJ Baba, L Meuse, MA Kay, MP Calos","Molecular Therapy 4 (2), 122-129",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10195811263230876349,110,2001
Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer,"MJTFD Vrancken Peeters, A Lieber, J Perkins, MA Kay","Biotechniques 20 (2), 278-285",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9343405639638525592,110,1996
Therapeutic short hairpin RNA expression in the liver: viral targets and vectors,"D Grimm, MA Kay","Gene therapy 13 (6), 563",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14229705235691826569,107,2006
Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype,"D Grimm, K Pandey, H Nakai, TA Storm, MA Kay","Journal of virology 80 (1), 426-439",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4191760733001056111,104,2006
Gene therapy for the hemophilias,"MA Kay, K High","Proceedings of the National Academy of Sciences 96 (18), 9973-9975",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14483432840394209859,103,1999
A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice,"AP McCaffrey, L Meuse, M Karimi, CH Contag, MA Kay","Hepatology 38 (2), 503-508",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5869106064963581021,102,2003
A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction,"H Nakai, CE Thomas, TA Storm, S Fuess, S Powell, JF Wright, MA Kay","Journal of virology 76 (22), 11343-11349",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16693838892723812111,102,2002
"IMAGe, a New Clinical Association of ","E Vilain, M Le Merrer, C Lecointre, F Desangles, MA Kay, P Maroteaux, ...","The Journal of Clinical Endocrinology & Metabolism 84 (12), 4335-4340",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2450188444975588924,102,1999
Advancing molecular therapies through in vivo bioluminescent imaging,"A McCaffrey, MA Kay, CH Contag","Molecular imaging 2 (2), 15353500200303124",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17007691393726228061,101,2003
Adenoviral vector and methods for making and using the same,"MA Kay, H Mizuguchi","US Patent 6,303,362",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10961452635022285338,99,2001
NF-κB activation is required for human endothelial survival during exposure to tumor necrosis factor-α but not to interleukin-1β or lipopolysaccharide,"K Zen, A Karsan, A Stempien-Otero, E Yee, J Tupper, X Li, T Eunson, ...","Journal of Biological Chemistry 274 (40), 28808-28815",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18095515450706011413,99,1999
Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing,"Y Wang, P Liang, F Lan, H Wu, L Lisowski, M Gu, S Hu, MA Kay, ...","Journal of the American College of Cardiology 64 (5), 451-459",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7808085973172100913,98,2014
Adenoviral vector and methods for making and using the same,"MA Kay, H Mizuguchi","US Patent 7,045,344",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17895754853146525311,96,2006
Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of α-L-iduronidase in mice with mucopolysaccharidosis type I,"MJ Osborn, RT McElmurry, CJ Lees, AP DeFeo, ZY Chen, MA Kay, ...","Molecular Therapy 19 (3), 450-460",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11212304092458755939,95,2011
Adeno‐associated virus gene repair corrects a mouse model of hereditary tyrosinemia ,"NK Paulk, K Wursthorn, Z Wang, MJ Finegold, MA Kay, M Grompe","Hepatology 51 (4), 1200-1208",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14133520839798100500,95,2010
Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level,"LEG Maniar, JM Maniar, ZY Chen, J Lu, AZ Fire, MA Kay","Molecular therapy 21 (1), 131-138",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16208318794500760257,93,2013
Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells,"SR Yant, MA Kay","Molecular and cellular biology 23 (23), 8505-8518",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1807384976118722121,91,2003
Novel minicircle vector for gene therapy in murine myocardial infarction,"M Huang, ZY Chen, S Hu, F Jia, Z Li, G Hoyt, RC Robbins, MA Kay, ...","Circulation 120 (11_suppl_1), S230-S237","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9561684547569467510,13268498988698418038",89,2009
A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8,"B Akache, D Grimm, X Shen, S Fuess, SR Yant, DS Glazer, J Park, ...","Molecular Therapy 15 (2), 330-339",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8037963349880268196,89,2007
Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells,"J Tolar, MJ O'shaughnessy, A Panoskaltsis-Mortari, RT McElmurry, S Bell, ...","Blood 107 (10), 4182-4188",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12243870686097715001,89,2006
Molecular analysis of chromosomal rearrangements in mammalian cells after ø C31-mediated integration,"A Ehrhardt, JA Engler, H Xu, AM Cherry, MA Kay","Human gene therapy 17 (11), 1077-1094",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7524433211255783419,88,2006
A bright cyan-excitable orange fluorescent protein facilitates dual-emission microscopy and enhances bioluminescence imaging ,"J Chu, Y Oh, A Sens, N Ataie, H Dana, JJ Macklin, T Laviv, ES Welf, ...","Nature biotechnology 34 (7), 760",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4804299168208515249,87,2016
Methods of in vivo gene transfer using a sleeping beauty transposon system,"MA Kay, S Yant","US Patent 6,613,752","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16470982371631404314,2664441170264766472",85,2003
Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration,"MJTFDV Peeters, GA Patijn, A Lieber, L Meuse, MA Kay","Human gene therapy 7 (14), 1693-1699",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8078815436409857079,85,1996
Clinical gene transfer studies for hemophilia B,KA High,"Seminars in thrombosis and hemostasis 30 (02), 257-267","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=148059719701801739,16793739499444865978",84,2004
A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia,"A Ehrhardt, H Xu, AM Dillow, DA Bellinger, TC Nichols, MA Kay","Blood 102 (7), 2403-2411",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16784781534825482360,84,2003
Inhibition of NF-κB activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liver,"A Lieber, CY He, L Meuse, C Himeda, C Wilson, MA Kay","Journal of virology 72 (11), 9267-9277",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2466880230252546192,84,1998
Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo,"A Lieber, MJV Peeters, L Meuse, N Fausto, J Perkins, MA Kay","Proceedings of the National Academy of Sciences 92 (13), 6210-6214",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6326736320387253321,83,1995
Thermodynamic stability of small hairpin RNAs highly influences the loading process of different mammalian Argonautes,"S Gu, L Jin, F Zhang, Y Huang, D Grimm, JJ Rossi, MA Kay","Proceedings of the National Academy of Sciences 108 (22), 9208-9213",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8517579767605064074,82,2011
A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase ϕC31 and the Sleeping Beauty transposase,"A Ehrhardt, H Xu, Z Huang, JA Engler, MA Kay","Molecular Therapy 11 (5), 695-706","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14292270290681101847,2558108844547959714",82,2005
Adeno-associated virus vectors for short hairpin RNA expression,"D Grimm, K Pandey, MA Kay","Methods in enzymology 392, 381-405",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16855875634943522710,82,2005
Adenovirus-mediated expression of ribozymes in mice.,"A Lieber, MA Kay","Journal of virology 70 (5), 3153-3158",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5038088862221498694,81,1996
Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I,"K Overturf, M Al-Dhalimy, CN Ou, M Finegold, R Tanguay, A Lieber, ...","Human gene therapy 8 (5), 513-521",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4640361038241468263,79,1997
RF peak detection method using a sequential baseband scheme,"S Youssef, R Winoto","US Patent 10,200,002","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8085064107289891050,15424939189100071174",78,2019
Capped small RNAs and ,"D Haussecker, D Cao, Y Huang, P Parameswaran, AZ Fire, MA Kay","Nature structural & molecular biology 15 (7), 714",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6874819660865973173,78,2008
Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication.,"JE Nelson, MA Kay","Journal of virology 71 (11), 8902-8907",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10379426450208729281,77,1997
Approaches for generating recombinant adenovirus vectors,"H Mizuguchi, MA Kay, T Hayakawa","Advanced drug delivery reviews 52 (3), 165-176",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12989299261703866098,76,2001
"Structural analysis of the Drosophila rpA1 gene, a member of the eucaryotic ‘A’type ribosomal protein family","S Qian, JY Zhang, MA Kay, M Jacobs-Lorena","Nucleic acids research 15 (3), 987-1003",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7166429322806305084,75,1987
Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B,"MA Hausl, W Zhang, N Müther, C Rauschhuber, HG Franck, EP Merricks, ...","Molecular Therapy 18 (11), 1896-1906",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12939230980070318084,73,2010
Selective translational regulation of ribosomal protein gene expression during early development of Drosophila melanogaster.,"MA Kay, M Jacobs-Lorena","Molecular and cellular biology 5 (12), 3583-3592",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7648812518560038527,73,1985
Recombinant AAV as a platform for translating the therapeutic potential of RNA interference,"F Borel, MA Kay, C Mueller","Molecular Therapy 22 (4), 692-701",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15378269260953636804,72,2014
The role of DNA-PKcs and artemis in opening viral DNA hairpin termini in various tissues in mice,"K Inagaki, C Ma, TA Storm, MA Kay, H Nakai","Journal of virology 81 (20), 11304-11321",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13795227412875578034,71,2007
Looking into the safety of AAV vectors,"MA Kay, H Nakai","Nature 424 (6946), 251",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=463580122488837915,71,2003
Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo,"A Ehrhardt, H Xu, MA Kay","Journal of virology 77 (13), 7689-7695",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17536934177008439129,71,2003
Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging,"Y Wang, WY Zhang, S Hu, F Lan, AS Lee, B Huber, L Lisowski, P Liang, ...","Circulation research 111 (12), 1494-1503",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7060711064052441376,70,2012
Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis …,"M Huang, P Nguyen, F Jia, S Hu, Y Gong, PE de Almeida, L Wang, D Nag, ...","Circulation 124 (11_suppl_1), S46-S54",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16314267344849267177,70,2011
miR-122 continues to blaze the trail for microRNA therapeutics,"D Haussecker, MA Kay","Molecular Therapy 18 (2), 240-242",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9677972696880486995,68,2010
Developmental genetics of ribosome synthesis in Drosophila,"MA Kay, M Jacobs-Lorena","Trends in Genetics 3, 347-351",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2615767920795686376,67,1987
Postintegrative gene silencing within the Sleeping Beauty transposition system,"BS Garrison, SR Yant, JG Mikkelsen, MA Kay","Molecular and cellular biology 27 (24), 8824-8833",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5124508650267776825,66,2007
Liver regeneration: prospects for therapy based on new technologies,"MA Kay, N Fausto","Molecular medicine today 3 (3), 108-115",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17744030431750250196,66,1997
A transfer-RNA-derived small RNA regulates ribosome biogenesis,"HK Kim, G Fuchs, S Wang, W Wei, Y Zhang, H Park, B Roy-Chaudhuri, ...","Nature 552 (7683), 57",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9954041363262623258,63,2017
Drugging RNAi,"D Haussecker, MA Kay","Science 347 (6226), 1069-1070","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17010022172075853332,9575643104115048335",61,2015
Slicing-independent RISC activation requires the argonaute PAZ domain,"S Gu, L Jin, Y Huang, F Zhang, MA Kay","Current Biology 22 (16), 1536-1542",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5386592989598884718,61,2012
Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice,"H Nakai, E Montini, S Fuess, TA Storm, L Meuse, M Finegold, M Grompe, ...","Molecular Therapy 7 (1), 101-111",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14710128593060341875,61,2003
Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand,"PS Linsley, MA Kay, CB Wilson, J Ledbetter, AA Aruffo, DL Hollenbaugh","US Patent 5,993,800",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15779182501215821475,61,1999
"Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo","DB Schowalter, JC Tubb, M Liu, CB Wilson, MA Kay","Gene therapy 4 (4), 351",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=336592245065641148,60,1997
Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene,"X Zhang, MW Epperly, MA Kay, ZY Chen, T Dixon, D Franicola, ...","Human gene therapy 19 (8), 820-826",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3862476331192154934,59,2008
AAV capsid library and AAV capsid proteins,"M Kay, D Grimm","US Patent 7,588,772","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4549350158619634460,4967029407417272455",58,2009
Somatic integration from an adenoviral hybrid vector into a hot spot in mouse liver results in persistent transgene expression levels in vivo,"A Ehrhardt, SR Yant, JC Giering, H Xu, JA Engler, MA Kay","Molecular Therapy 15 (1), 146-156",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3590112468871206792,58,2007
A modified urokinase plasminogen activator induces liver regeneration without bleeding,"A Lieber, MJTFDV Peeters, A Gown, J Perkins, MA Kay","Human gene therapy 6 (8), 1029-1037",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3283394650348859790,58,1995
Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo,"K Ohashi, F Park, MA Kay","Human gene therapy 13 (5), 653-663",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13937976786299468047,57,2002
"DNA palindromes with a modest arm length of≳ 20 base pairs are a significant target for recombinant adeno-associated virus vector integration in the liver, muscles, and heart …","K Inagaki, SM Lewis, X Wu, C Ma, DJ Munroe, S Fuess, TA Storm, MA Kay, ...","Journal of virology 81 (20), 11290-11303",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4287717407087362997,56,2007
Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo,"E Riu, D Grimm, Z Huang, MA Kay","Human gene therapy 16 (5), 558-570",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4690706473529564112,54,2005
The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo,"F Park, K Ohashi, MA Kay","Molecular Therapy 8 (2), 314-323",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13484877260362478485,54,2003
Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector …,"CB Wilson, LJ Embree, D Schowalter, R Albert, A Aruffo, D Hollenbaugh, ...","Journal of virology 72 (9), 7542-7550",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1022146580558213284,54,1998
Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo,"A Lieber, CY He, MA Kay","Nature biotechnology 15 (13), 1383",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9514491807901841783,54,1997
Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression,"DB Schowalter, L Meuse, CB Wilson, PS Linsley, MA Kay","Gene therapy 4 (8), 853",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=655399178215814275,54,1997
A mini-intronic plasmid (MIP): a novel robust transgene expression vector in vivo and in vitro,"J Lu, F Zhang, MA Kay","Molecular Therapy 21 (5), 954-963",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14853999561930683558,52,2013
The extragenic spacer length between the 5′ and 3′ ends of the transgene expression cassette affects transgene silencing from plasmid-based vectors,"J Lu, F Zhang, S Xu, AZ Fire, MA Kay","Molecular Therapy 20 (11), 2111-2119",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5911995796316540371,52,2012
Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors,"B Moldt, SR Yant, PR Andersen, MA Kay, JG Mikkelsen","Human gene therapy 18 (12), 1193-1204",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18247322976432770565,51,2007
Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency,"X Shen, T Storm, MA Kay","Molecular Therapy 15 (11), 1955-1962",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7760221741789023457,51,2007
Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult mice,"S Beer, DI Bellovin, JS Lee, K Komatsubara, LS Wang, H Koh, K Börner, ...","Molecular Therapy 18 (1), 161-170",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17395987369830942140,50,2010
A rapid protocol for construction and production of high-capacity adenoviral vectors,"L Jager, MA Hausl, C Rauschhuber, NM Wolf, MA Kay, A Ehrhardt","Nature protocols 4 (4), 547",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5157945721327399315,50,2009
Real-time in vivo imaging of stem cells following transgenesis by transposition,"J Tolar, M Osborn, S Bell, R McElmurry, L Xia, M Riddle, ...","Molecular Therapy 12 (1), 42-48",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9847322667010955690,49,2005
Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant,"SP Melo, L Lisowski, E Bashkirova, HH Zhen, K Chu, DR Keene, ...","Molecular Therapy 22 (4), 725-733",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=419742558383389466,47,2014
Combined proteomic–RNAi screen for host factors involved in human hepatitis delta virus replication,"D Cao, D Haussecker, Y Huang, MA Kay","Rna 15 (11), 1971-1979",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10878691085882784582,47,2009
Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo,"TM Kolodka, M Finegold, SLC Woo","Somatic cell and molecular genetics 19 (5), 491-497",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13887527901757037958,47,1993
Optimization of cis-acting elements for gene expression from nonviral vectors in vivo,"A Ehrhardt, PD Peng, H Xu, L Meuse, MA Kay","Human gene therapy 14 (3), 215-225",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10797378325795892840,45,2003
Adenovirus-mediated transfer of the amphotropic retrovirus receptor cDNA increases retroviral transduction in cultured cells,"A Lieber, MJTFDV Peeters, MA Kay","Human gene therapy 6 (1), 5-11",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13571240686775232042,45,1995
Photopolymerizable inkjet ink,T Hiraoka,"US Patent 10,259,226","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5786600192648037206,9952870768632929630",44,2019
Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune …,"DB Schowalter, CL Himeda, BL Winther, CB Wilson, MA Kay","Journal of virology 73 (6), 4755-4766",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2525881254997976386,43,1999
HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene.,"V Sandig, P Löser, A Lieber, MA Kay, M Strauss","Gene therapy 3 (11), 1002-1009",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10536168716861727607,42,1996
High-efficiency retrovirus-mediated gene transfer into the livers of mice,"GA Patijn, A Lieber, L Meuse, B Winther, MA Kay","Human gene therapy 9 (10), 1449-1456",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11794262710592256153,41,1998
"Novel codon-optimized mini-intronic plasmid for efficient, inexpensive, and xeno-free induction of pluripotency","S Diecke, J Lu, J Lee, V Termglinchan, NG Kooreman, PW Burridge, ...","Scientific reports 5, 8081",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10979023795722795643,40,2015
"Identification of an interstitial deletion in an adult female with schizophrenia, mental retardation, and dysmorphic features: further support for a putative schizophrenia …","RL Bennett, M Karayiorgou, CA Sobin, TH Norwood, MA Kay","American journal of human genetics 61 (6), 1450",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9401639066024006463,40,1997
Reconstitution of enzymatic activity in hepatocytes of phenylalanine hydroxylase-deficient mice,"TJ Liu, MA Kay, GJ Darlington, SLC Woo","Somatic cell and molecular genetics 18 (1), 89-96",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18018416384319491563,40,1992
Expression determinants of mammalian argonaute proteins in mediating gene silencing,"PN Valdmanis, S Gu, N Schüermann, P Sethupathy, D Grimm, MA Kay","Nucleic acids research 40 (8), 3704-3713",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18261685016433146578,39,2011
Immunomodulation to enhance gene therapy,"C Wilson, MA Kay","Nature medicine 1 (9), 887",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3947016700426849453,39,1995
AAV vectors and tumorigenicity,MA Kay,"Nature biotechnology 25 (10), 1111",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15033684081106489977,38,2007
Stability and repeat regeneration potential of the engineered liver tissues under the kidney capsule in mice,"K Ohashi, MA Kay, T Yokoyama, H Kuge, H Kanehiro, M Hisanaga, S Ko, ...","Cell transplantation 14 (9), 621-627",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4152049823834751791,37,2005
Epstein‐Barr virus vectors provide prolonged robust factor IX expression in mice,"CR Sclimenti, AS Neviaser, EJ Baba, L Meuse, MA Kay, MP Calos","Biotechnology progress 19 (1), 144-151",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10129805059088502175,37,2003
In vitro ligation-based cloning of foreign DNAs into the E3 and E1 deletion regions for generation of recombinant adenovirus vectors,"H Mizuguchi, MA Kay, T Hayakawa","Biotechniques 30 (5), 1112-1116",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10977793705475866440,35,2001
Bioengineered AAV capsids with combined high human liver transduction in vivo and unique humoral seroreactivity,"NK Paulk, K Pekrun, E Zhu, S Nygaard, B Li, J Xu, K Chu, C Leborgne, ...","Molecular Therapy 26 (1), 289-303","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16123160440467233251,8931697984219566100",34,2018
Enhanced efficiency of induced pluripotent stem cell generation,"J Wu, MT Longaker, MA Kay, N Sung, FJ Jia, ZY Chen, N Panetta, ...","US Patent App. 12/931,476","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1883712771117676909,14485381153636330994",34,2011
Upregulation of the microRNA cluster at the ,"PN Valdmanis, B Roy-Chaudhuri, HK Kim, LC Sayles, Y Zheng, ...","Oncogene 34 (1), 94",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18112147089599169430,33,2015
Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase,"F Puzzo, P Colella, MG Biferi, D Bali, NK Paulk, P Vidal, F Collaud, ...","Science translational medicine 9 (418), eaam6375",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=58521363702869406,31,2017
"Immune responses to AAV and to factor IX in a phase I study of AAV-mediated, liver-directed gene transfer for hemophilia B.","KA High, CS Manno, DE Sabatino, S Hutchison, M Dake, M Razavi, ...","Blood 102 (11), 154A-155A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11655300862498842103,31,2003
erbB-2 knockout employing an intracellular single-chain antibody (sFv) accomplishes specific toxicity in erbB-2-expressing lung cancer cells.,"J Grim, J Deshane, M Feng, A Lieber, M Kay, DT Curiel","American journal of respiratory cell and molecular biology 15 (3), 348-354",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1190445382667990650,31,1996
Early clinical trial results following administration of a low dose of a novel self complementary adeno-associated viral vector encoding human Factor IX in two subjects with …,"A Nathwani, E Tuddenham, C Rosales, J McIntosh, A Riddell, P Rustagi, ...","Blood 116 (21), 248-248",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15060071433023505350,30,2010
"1002. Immune Responses to AAV and to Factor IX in a Phase I Study of AAV-Mediated, Liver-Directed Gene Transfer for Hemophilia B","K High, C Manno, D Sabatino, S Hutchison, M Dake, M Razavi, R Kaye, ...","Molecular Therapy 9, S383-S384",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2410364200692088608,30,2004
Organ size control is dominant over Rb family inactivation to restrict proliferation in vivo,"U Ehmer, AF Zmoos, RK Auerbach, D Vaka, AJ Butte, MA Kay, J Sage","Cell reports 8 (2), 371-381",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8033376168582183272,29,2014
Gene transfer to mouse heart and skeletal muscles using a minicircle expressing human vascular endothelial growth factor,"S Stenler, A Andersson, OE Simonson, KE Lundin, ZY Chen, MA Kay, ...","Journal of cardiovascular pharmacology 53 (1), 18-23",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4571790795702602585,29,2009
Rapid and stable knockdown of an endogenous gene in retinal pigment epithelium,"DM Paskowitz, KP Greenberg, D Yasumura, D Grimm, H Yang, ...","Human gene therapy 18 (10), 871-880",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18417512808926841872,29,2007
Pathways of removal of free DNA vector ends in normal and DNA-PKcs–deficient SCID mouse hepatocytes transduced with rAAV vectors,"H Nakai, TA Storm, S Fuess, MA Kay","Human gene therapy 14 (9), 871-881",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15260325598276416477,29,2003
Free DNA ends are essential for concatemerization of synthetic double-stranded adeno-associated virus vector genomes transfected into mouse hepatocytes in vivo,"H Nakai, S Fuess, TA Storm, LA Meuse, MA Kay","Molecular Therapy 7 (1), 112-121",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6705308751466573802,29,2003
The expanding repertoire of circular RNAs,"PN Valdmanis, MA Kay","Molecular Therapy 21 (6), 1112-1114",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11166204161415818873,28,2013
AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence,"Z Wang, L Lisowski, MJ Finegold, H Nakai, MA Kay, M Grompe","Molecular Therapy 20 (10), 1902-1911",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18130721263370641868,28,2012
Recombinant vectors for reconstitution of liver,"MA Kay, A Lieber","US Patent 5,980,886",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11369914295517413463,28,1999
Immunobiology of naive and genetically modified HLA-class-I-knockdown human embryonic stem cells,"T Deuse, M Seifert, N Phillips, A Fire, D Tyan, M Kay, PS Tsao, X Hua, ...","J Cell Sci 124 (17), 3029-3037",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9972281398945144847,27,2011
Ribozymes for treating hepatitis C,"MA Kay, A Lieber","US Patent 6,107,027","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7245478315436482893,2497585895260837346",27,2000
Translational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogs,"TC Nichols, MH Whitford, VR Arruda, HH Stedman, MA Kay, KA High","Human Gene Therapy Clinical Development 26 (1), 5-14",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=982553743098537619,26,2014
An in vitro-identified high-affinity nucleosome-positioning signal is capable of transiently positioning a nucleosome in vivo,"LE Gracey, ZY Chen, JM Maniar, A Valouev, A Sidow, MA Kay, AZ Fire","Epigenetics & chromatin 3 (1), 13",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=543926432938453741,26,2010
101. Toxicology and Biodistribution Studies of a Recombinant Adeno-Associated Virus 2 (rAAV2) Alpha-1 Antitrypsin (AAT) Vector,"AE Poirier, LA Combee, AT Martino, TR Flotte","Molecular Therapy 9 (S1), S40","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5628542885489859622,3719663452278745765",26,2004
Hepatic gene therapy using adeno-associated virus vectors,"GA Patijn, MA Kay","Seminars in liver disease 19 (01), 61-69",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3741704274921721186,26,1999
Expansion of donor hepatocytes after recombinant adenovirus‐induced liver regeneration in mice,"MTF Vrancken Peeters, GA Patijn, A Lieber, J Perkins, MA Kay","Hepatology 25 (4), 884-888",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4585061585373483794,26,1997
"Future of rAAV gene therapy: platform for RNAi, gene editing, and beyond","PN Valdmanis, MA Kay","Human gene therapy 28 (4), 361-372",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1077531925791925806,25,2017
Ribosomal DNA integrating rAAV-rDNA vectors allow for stable transgene expression,"L Lisowski, A Lau, Z Wang, Y Zhang, F Zhang, M Grompe, MA Kay","Molecular Therapy 20 (10), 1912-1923",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1985205988041180871,25,2012
Human leukocyte antigen I knockdown human embryonic stem cells induce host ignorance and achieve prolonged xenogeneic survival,"T Deuse, M Seifert, N Phillips, A Fire, D Tyan, M Kay, PS Tsao, X Hua, ...","Circulation 124 (11_suppl_1), S3-S9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10829226789924861362,24,2011
Enhanced sleeping beauty transposon system and methods for using the same,"MA Kay, S Yant","US Patent 7,985,739",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5203781613802331099,24,2011
A universal system to select gene-modified hepatocytes in vivo,"S Nygaard, A Barzel, A Haft, A Major, M Finegold, MA Kay, M Grompe","Science translational medicine 8 (342), 342ra79-342ra79",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12987332540054778375,23,2016
"Circular nucleic acid vectors, and methods for making and using the same","MA Kay, ZY Chen","US Patent 7,897,380",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9455109533781137440,23,2011
Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery,"H Zayed, L Xia, A Yerich, SR Yant, MA Kay, M Puttaraju, GJ McGarrity, ...","Molecular Therapy 15 (7), 1273-1279",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5787240987854716102,23,2007
Changing patterns of femoral and skeletal mineralization during growth in juvenile X-linked hypophosphatemic mice.,"MA Kay, MH Meyer, PR Delzer, JRA Meyer","Mineral and electrolyte metabolism 11 (6), 374-380",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=880953209519215558,23,1985
Regulation of microRNA-mediated gene silencing by microRNA precursors,"B Roy-Chaudhuri, PN Valdmanis, Y Zhang, Q Wang, QJ Luo, MA Kay","Nature structural & molecular biology 21 (9), 825",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1443563565750239016,22,2014
Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B,"TC Nichols, RA Raymer, HWG Franck, EP Merricks, DA Bellinger, ...","Haemophilia 16, 19-23",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5241374651260187085,22,2010
Complementation of a human adenovirus early region 4 deletion mutant in 293 cells using adenovirus-polylysine-DNA complexes.,"A Scaria, DT Curiel, MA Kay","Gene therapy 2 (4), 295-298",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3772096574393127955,22,1995
Transient organic aciduria and methemoglobinemia with acute gastroenteritis,"MA KAY, W O'BRIEN, B KESSLER, R MCVIE, S URSIN, K DIETRICH, ...","Pediatrics 85 (4), 589-592",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3683030608722787916,22,1990
Survival advantage of both human hepatocyte xenografts and genome-edited hepatocytes for treatment of α-1 antitrypsin deficiency,"F Borel, Q Tang, G Gernoux, C Greer, Z Wang, A Barzel, MA Kay, ...","Molecular Therapy 25 (11), 2477-2489",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11161131104189672823,21,2017
Weak base pairing in both seed and 3′ regions reduces RNAi off-targets and enhances si/shRNA designs,"S Gu, Y Zhang, L Jin, Y Huang, F Zhang, MC Bassik, M Kampmann, ...","Nucleic acids research 42 (19), 12169-12176",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11772230721725146264,21,2014
rAAV-mediated tumorigenesis: still unresolved after an AAV assault,"PN Valdmanis, L Lisowski, MA Kay","Molecular Therapy 20 (11), 2014-2017",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3616687485980523607,21,2012
"Liver-specific gene expression cassettes, and methods of use","CH Miao, MA Kay","US Patent 7,351,813",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4280967634930720545,21,2008
Adeno-associated viral vector-mediated delivery of DNA to cells of the liver,"RO Snyder, LK Cohen, MA Kay, O Danos, AR Thompson","US Patent 6,936,243",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=661738945318517696,21,2005
Hepatic gene therapy for haemophilia B,"CA Lee, CM Kessler, D Varon, U Martinowitz, M Heim, MA KAY","Haemophilia: State of the Art 4 (4), 389-392",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9177866575325065158,21,1998
A story of mice and men,"AP McCaffrey, MA Kay","Gene therapy 9 (23), 1563-1563",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7733918414581869219,20,2002
Efficient gene transduction to cultured hepatocytes by HIV-1 derived lentiviral vector,"K Ohashi, F Park, RH Schwall, MA Kay","Transplantation proceedings 34 (5), 1431-1433",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10907158223326171590,20,2002
RNA interference–induced hepatotoxicity results from loss of the first synthesized isoform of microRNA-122 in mice,"PN Valdmanis, S Gu, K Chu, L Jin, F Zhang, EM Munding, Y Zhang, ...","Nature medicine 22 (5), 557",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6932490617995743878,19,2016
Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver,"K Ohashi, H Nakai, LB Couto, MA Kay","Human gene therapy 16 (3), 299-306",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9962446203799072924,19,2005
Development of a clinical protocol for hepatic gene transfer: lessons learned in preclinical studies,"FD Ledley, MR Adams, HE Soriano, G Darlington, M Finegold, R Lanford, ...","Pediatric research 33 (4), 313",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13592803233695686736,19,1993
Non-silencing selectable marker genes and methods of use,"MA Kay, J Lu","US Patent App. 10/006,047",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1886264439441238050,18,2018
A proposed rAAV-liver directed clinical trial for hemophilia B,H Nakai,"Blood 96, 798a",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16353709409118957156,18,2000
"MicroRNAs in Cancer: The 22nd Hiroshima Cancer Seminar/The 4th Japanese Association for RNA Interference Joint International Symposium, 30 August 2012, Grand Prince Hotel Hiroshima","H Tahara, MA Kay, W Yasui, E Tahara","Japanese journal of clinical oncology 43 (5), 579-582",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9822781324547772956,17,2013
Hepatic parenchymal replacement in mice by transplanted allogeneic hepatocytes is facilitated by bone marrow transplantation and mediated by CD4 cells,"KL Streetz, R Doyonnas, D Grimm, DD Jenkins, S Fuess, S Perryman, ...","Hepatology 47 (2), 706-718",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14462553562070184455,17,2008
A phase I/II clinical trial for liver directed AAV-mediated gene transfer for severe hemophilia B.,"MA Kay, K High, B Glader, CS Manno, S Hutchinson, M Dake, M Razavi, ...","Blood 100 (11), 115A-115A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17889355090756416565,17,2002
Nuclear import of moloney murine leukemia virus DNA mediated by adenovirus preterminal protein is not sufficient for efficient retroviral transduction in nondividing cells,"A Lieber, MA Kay, ZY Li","Journal of virology 74 (2), 721-734",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2396077381837991552,17,2000
Human gene therapy: present and future,"MA Kay, KP Ponder, SLC Woo","Breast cancer research and treatment 21 (2), 83-93",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18010876368983403637,17,1992
Identification and germline transformation of the ribosomal protein ,"MA Kay, JY Zhang, M Jacobs-Lorena","Molecular and General Genetics MGG 213 (2-3), 354-358",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8311264706379082927,17,1988
Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity,"IP Winters, SH Chiou, NK Paulk, CD McFarland, PV Lalgudi, RK Ma, ...","Nature communications 8 (1), 2053",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9459722064929880635,16,2017
Regulated complex assembly safeguards the fidelity of ,"Y Wang, D Pryputniewicz-Dobrinska, EÉ Nagy, CD Kaufman, M Singh, ...","Nucleic acids research 45 (1), 311-326",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6082100399934749236,16,2016
RNAi expression constructs with liver-specific enhancer/promoter,"PW Roelvink, DA Suhy, AA Kolykhalov, MA Kay, JC Giering","US Patent 8,008,468",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13817976017189648737,16,2011
Heterotopically transplanted hepatocyte survival depends on extracellular matrix components,"K Ohashi, MA Kay, H Kuge, T Yokoyama, H Kanehiro, M Hisanaga, S Ko, ...","Transplantation proceedings 37 (10), 4587-4588",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13169794527714944604,16,2005
Genomic progression in mouse models for liver tumors,"AD Tward, KD Jones, S Yant, MA Kay, R Wang, JM Bishop","Cold Spring Harbor symposia on quantitative biology 70, 217-224",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15906233787080754077,16,2005
The anti-genomic (negative) strand of Hepatitis C Virus is not targetable by shRNA,"L Lisowski, M Elazar, K Chu, JS Glenn, MA Kay","Nucleic acids research 41 (6), 3688-3698",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7715595061515124497,15,2013
Erratum: wandering eye for RNAi,J Rossi,"Nature medicine 14 (7), 789",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9680220492516634400,15,2008
Promoterless gene targeting without nucleases rescues lethality of a Crigler‐Najjar syndrome mouse model,"F Porro, G Bortolussi, A Barzel, A De Caneva, A Iaconcig, S Vodret, ...","EMBO molecular medicine 9 (10), 1346-1355",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4262687542616792335,14,2017
Methods and apparatus for nucleic acid synthesis using oligo-templated polymerization,"MA Kay, A Barzel","US Patent App. 14/605,538",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8334438078055823749,14,2015
Gutted adenovirus: a rising star on the horizon?,"A Ehrhardt, MA Kay","Gene therapy 12 (21), 1540",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15574483115268122754,14,2005
cMet activation allows persistent engraftment of ectopically transplanted xenogenic human hepatocytes in mice,"K Ohashi, L Meuse, R Schwall, MA Kay",,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5483048925414636735,14,2001
Adeno-associated viral vector-based methods and compositions for introducing an expression cassette into a cell,"H Nakai, MA Kay","US Patent 7,060,497",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12259252747346395088,13,2006
Engineering cellular resistance to HIV,"MA Kay, BD Walker","N Engl J Med 370 (10), 968-9",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7295234711088017321,12,2014
Helper dependent adenoviral vector system and methods for using the same,"A Ehrhardt, MA Kay","US Patent 6,943,012",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10534349971179670319,11,2005
Human immune responses to AAV-2 capsid may limit duration of expression in liver-directed gene transfer in humans with hemophilia B.,"K High, M Tigges, C Manno, D Sabatino, V Arruda, R Herzog, P Rustagi, ...","Blood 104 (11), 413-413",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10194087713052000212,11,2004
Adenovirus vectors for hepatic gene transfer in animals,MA Kay,"Chest 111 (6), 138S-138S",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8749019191466883499,11,1997
miR-122 removal in the liver activates imprinted microRNAs and enables more effective microRNA-mediated gene repression,"PN Valdmanis, HK Kim, K Chu, F Zhang, J Xu, EM Munding, J Shen, ...","Nature communications 9 (1), 5321",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14595989170481778616,10,2018
Selecting the best AAV capsid for human studies,MA Kay,"Molecular Therapy 23 (12), 1800-1801",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17047332080752667550,10,2015
"Self-complementary parvoviral vectors, and methods for making and using the same","MA Kay, D Grimm","US Patent 9,150,882","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8732476968171926371,3008270198005004956",10,2015
System for simultaneous tissue-specific and disease-specific regulation of therapeutic gene expression,"YH Chyung, PD Peng, MA Kay","Human gene therapy 14 (13), 1255-1264",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11206213606529783588,10,2003
A phase I trial of AAV-mediated muscle directed gene transfer for hemophilia B,CS Manno,Thromb Haemost,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15909878573917258857,10,2001
Extracellular matrix component cotransplantation prolongs survival of heterotopically transplanted human hepatocytes in mice,"K Ohashi, MA Kay","Transplantation proceedings 36 (8), 2469-2470",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9558981927892108960,9,2004
Mice comprising engrafted functional human hepatocytes,"MA Kay, K Ohashi","US Patent 6,660,905",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3104355003362074355,9,2003
A 5′ Noncoding Exon Containing Engineered Intron Enhances Transgene Expression from Recombinant AAV Vectors ,"J Lu, JA Williams, J Luke, F Zhang, K Chu, MA Kay","Human gene therapy 28 (1), 125-134",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7601883982759832197,8,2017
Methods for delivering recombinant adeno-associated virus virions to the liver of a mammal,"M Kay, K High, L Couto","US Patent App. 11/406,867",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11943953468698610372,8,2006
Minicircle DNA vector preparations and methods of making and using the same,"ZY Chen, MA Kay","US Patent 8,236,548","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10830377803491457685,14046765380496971451",7,2012
Efficient inhibition of in-stent restenosis by controlled stent-based inhibition of elastase: a pilot study,"F Ganaha, K Ohashi, YS Do, J Lee, K Sugimoto, H Minamiguchi, ...","Journal of vascular and interventional radiology 15 (11), 1287-1293",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9992990217516751895,7,2004
Helper dependent adenoviral vector system and methods for using the same,"A Ehrhardt, M Kay","US Patent App. 10/753,962",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2808498237727673266,7,2004
"Donor-derived, liver-specific protein expression after bone marrow transplantation","DD Jenkins, K Streetz, M Tataria, D Sahar, M Kurobe, MT Longaker, ...","Transplantation 78 (4), 530-536",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14655782397091506992,7,2004
Rock bit,MA Kay,"US Patent 5,366,032",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3570017888866204842,7,1994
Bioengineered viral platform for intramuscular passive vaccine delivery to human skeletal muscle,"NK Paulk, K Pekrun, GW Charville, K Maguire-Nguyen, MN Wosczyna, ...","Molecular Therapy-Methods & Clinical Development 10, 144-155",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3068693790860128226,6,2018
Increased precursor microRNA-21 following status epilepticus can compete with mature microRNA-21 to alter translation,"K Chak, B Roy-Chaudhuri, HK Kim, KC Kemp, BE Porter, MA Kay","Experimental neurology 286, 137-146",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8596267668201043913,6,2016
Methods and compositions for rnai mediated inhibition of gene expression in mammals,"MA Kay, A McCaffrey","US Patent App. 12/576,052",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6535704142034479564,6,2010
Good news on the clinical gene transfer front,"JM Wilson, B Gansbacher, KI Berns, F Bosch, MA Kay, L Naldini, YQ Wei","Human gene therapy 19 (5), 429-430",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12552399721487602227,6,2008
817. Nonrandom Insertion Site Preferences for the SB Transposon In Vitro and In Vivo,"SR Yant, X Wu, Y Huang, B Daigle, BA Garrison, SM Burgess, MA Kay","Molecular Therapy 9, S309-S310",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6199138259513380171,6,2004
Minimal plasmid vectors that provide for persistent and high level gene expression and methods for using the same,"M Kay, N Hiroyuki","US Patent App. 10/642,362",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15998337717911065968,6,2004
Methods for delivering recombinant adeno-associated virus virions to the liver of a mammal,"M Kay, K High, L Couto","US Patent App. 10/405,047",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5764575203510392048,6,2004
RNA interference gene therapy: RNA interference gets infectious,"AP McCaffrey, MA Kay","Gene Therapy 10 (15), 1205",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9857670931827232945,6,2003
Methods and compositions for enhanced stability of non-adenoviral DNA,"MA Kay, A Lieber","US Patent 6,132,989",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14609870884418005103,6,2000
Method for continuous infusion into the portal vein of mice,"GA Patijn, OT Terpstra, MA Kay","Comparative Medicine 48 (4), 379-383",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1636853601595126768,6,1998
Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies,"MA Kay, NK PAULK","US Patent 10,179,176","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=977077010541193745,2972568569830380051",5,2019
Mini-intronic plasmid vectors,"MA Kay, J Lu","US Patent 9,347,073",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10762122654107777696,5,2016
Method of expanding human hepatocytes in vivo,"M Grompe, H Azuma, M Al-Dhalimy, MA Kay","US Patent 8,569,573",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14999446104895405991,5,2013
Non-disruptive gene targeting,"MA Kay, M Porteus, J Barker, J Checketts, R Voit, A Barzel","US Patent App. 13/838,927",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2440269060557623116,5,2013
A simple and rapid minicircle DNA vector manufacturing system,"MA Kay, CY He, ZY Chen","Nature biotechnology 28 (12), 1287",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7110722351115967378,5,2010
12. Therapeutic Potential of the Chimeric Adenovirus 5/40 as Vector for Intestine-Directed Gene Therapy,"E Rodriguez, C Romero, M Ferrer, JF Burgueño, E Fernandez, E Gil, ...","Molecular Therapy 13, S5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11209988287617844410,5,2006
Assessing the risk of inadvertent germline transmission of vector DNA following intravascular delivery of rAAV vector.,"VR Arruda, J Schuettrumpf, L Couto, D Leonard, K Addya, JH Liu, ...","Blood 100 (11), 869A-869A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14424900206291575828,5,2002
Gene therapy: A status report,"DB Schowalter, MA Kay","Pediatric annals 26 (9), 562-568",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15260157365788912283,5,1997
GENE-THERAPY FOR HEMOPHILIA-B-CYCLOSPORINE TREATMENT INCREASES THE PERSISTENCE OF ADENOVIRUS-MEDIATED FACTOR-IX EXPRESSION IN HEMOPHILIA-B DOGS,"RC Eisensmith, B Fang, MA Kay, CN Landen, RE Cross, DA Bellinger, ...","Blood 84 (10), A255-A255",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1963830652257604131,5,1994
Article Commentary: Hepatocyte Transplantation for Liver Gene Therapy,MA Kay,"Cell transplantation 2 (5), 405-406",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17378742619488489005,5,1993
Characterization of Vector-Based Delivery of ,"N Phillips, MA Kay","Human gene therapy 25 (7), 651-661",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14904704055824640803,4,2014
Minigene expression cassette,"M Kay, M Hebert, PW Roelvink, DA Suhy","US Patent 8,129,510",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15871483870592455052,4,2012
Chimeric AAV capsid proteins,"M Kay, D Grimm","US Patent 8,067,014",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10213595284031791343,4,2011
Adeno-associated viral vector mediated gene transfer for hemophilia B,"AC Nathwani, EGD Tuddenham, S Rangarajan, C Rosales, JH McIntosh, ...","Blood 118 (21), 5-5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12172375873712195000,4,2011
Animals comprising human hepatocellular tissue,"M Kay, K Ohashi","US Patent App. 10/636,510",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14600253509439095662,4,2004
Hemophilia A gene therapy in mouse and dog models using an AAV-FVIII vector.,"L Couto, C Scallan, HY Jiang, XB Qian, S Patarroyo-White, A Parker, ...","Blood 100 (11), 117A-117A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3937601608225446970,4,2002
GENE-THERAPY FOR HEMOPHILIA-B-HOST IMMUNOSUPPRESSION PROLONGS THE THERAPEUTIC EFFECT OF ADENOVIRUS-MEDIATED GENE-TRANSFER,"B Fang, RC Eisensmith, H Wang, MA Kay, RE Cross, CN Landen, ...","Journal of Cellular Biochemistry, 363-363",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12239872095776545873,4,1995
Escherichia coli sepsis and prolonged hypophosphatemia following exertional heat stroke,"MA KAY, EDB MCCABE","Pediatrics 86 (2), 307-309",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12972881313862925167,4,1990
Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism,"MA Kay, NK Paulk","US Patent 10,385,320",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10861345287362489545,3,2019
An orange calcium-modulated bioluminescent indicator for non-invasive activity imaging,"Y Oh, Y Park, JH Cho, H Wu, NK Paulk, LX Liu, N Kim, MA Kay, JC Wu, ...","Nature chemical biology 15 (5), 433",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3596173169110866595,3,2019
Whole-body rescue of Pompe disease with AAV liver delivery of engineered secretable GAA transgenes,"P Colella, F Puzzo, M Biferi, D Bali, N Paulk, P Vidal, F Collaud, ...","Neuromuscular Disorders 27, S246",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18211377089310953308,3,2017
Sequence-modified antibiotic resistance genes provide sustained plasmid-mediated transgene expression in mammals,"J Lu, F Zhang, AZ Fire, MA Kay","Molecular Therapy 25 (5), 1187-1198","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2769150155019329553,17095909300925904379",3,2017
rAAV is extensively and differentially post-translationally modified in human versus insect cell line production methods,"NK Paulk, NG Rumachik, CM Adams, R Leib, S Stamnes, KH Holt, ...","MOLECULAR THERAPY 25 (5), 46-46",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8845180003627152399,3,2017
Viral vectors take on HIV infection,"ED Mellins, MA Kay","New England Journal of Medicine 373 (8), 770-772",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11300488628760642559,3,2015
Minicircle DNA vector preparations and methods of making and using the same,"ZY Chen, MA Kay","US Patent 8,945,885",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10057754877600468224,3,2015
Double knockdown of Prolyyl hydroxylase and factor inhibiting HIF with non-Viral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial …,"M Huang, P Nguyen, F Jia, S Hu, Y Gong, PE de Almeida, L Wang, D Nag, ...","Circulation 124 (11 Suppl), S46",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=85818591282708045,3,2011
Prime time for small RNA-based therapeutics,MA Kay,"Human gene therapy 19 (1), 15-16",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16234697768952301415,3,2008
Development of a transposon system for site-specific DNA integration in mammalian cells,"S Yant, M Kay","US Patent App. 11/413,481",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8963003163451148413,3,2006
742. Molecular Evolution of Adeno-Associated Viral (AAV) Vectors Via DNA Family Shuffling of Primate and Non-Primate Serotypes,"D Grimm, JS Lee, TA Storm, MA Kay","Molecular Therapy 13, S287",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1360018028441127167,3,2006
27 RNAi in drug development: Practical considerations,"D Samarsky, M Taylor, MA Kay, AP McCaffrey","RNA Interference Technology: From Basic Science to Drug Development, 384",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10248992590502534976,3,2005
Metal coating method and metal-coated material,"K Niihara, YH Choa, Y Hayashi","US Patent App. 10/406,244",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6202605085015473452,3,2004
Assessing the risk of inadvertant germline transmision of recombinant AAV-2 vector,"VR Arruda, J Schuettrumpf, JH Liu, K Addya, D Leonard, L Couto, A Chew, ...","MOLECULAR THERAPY 7 (5), S161-S162",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15610970654903267989,3,2003
Development of a high-performance liquid chromatographic assay for G418 sulfate (Geneticin).,"C Bethune, T Bui, ML Liu, MA Kay, RJ Ho","Antimicrobial agents and chemotherapy 41 (3), 661-664",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16608969266127282237,3,1997
SELECTIVE IMMUNE INHIBITION OF RECOMBINANT ADENOVIRUS VECTORS USING SOLUBLE CTLA4IG RESULTS IN PERSISTENT GENE-EXPRESSION FROM HEPATOCYTES IN-VIVO,"MA Kay, AX Holterman, L Meuse, H Ochs, P Linsley, C Wilson","JOURNAL OF CELLULAR BIOCHEMISTRY, 366-366",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12402686077930693625,3,1995
MYOD-BASED GENE-THERAPY FOR MYOCARDIAL-INFARCTION,"CE Murry, MA Kay, CW Covin, T Bartosek, SM Schwartz","Circulation 90 (4), 518-518",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7656202871477146817,3,1994
RECOMBINANT ADENOVIRAL VECTORS FOR HEPATIC GENE-THERAPY,"MA Kay, QT LI, M Finegold, LD STRATFORDPERRICAUDET, SLC Woo","JOURNAL OF CELLULAR BIOCHEMISTRY, 207-207",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7998256611973866463,3,1993
Divergent Synthesis of Densely Substituted Arenes and Pyridines ,"JF Tan, CT Bormann, FG Perrin, FM Chadwick, K Severin, N Cramer",Journal of the American Chemical Society,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14009373690624472880,8502840806040856240,14036004787695108431",2,2019
Novel recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies,"MA Kay, NK Paulk","US Patent App. 15/681,267",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12958730415367053068,2,2017
253. Expanded Packaging Capacity of AAV by Lumenal Charge Alteration,"M Tiffany, MA Kay","Molecular Therapy 24, S99-S100",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12661490829630270082,2,2016
Methods and compositions for RNAi mediated inhibition of gene expression in mammals,"M Kay, A McCaffrey","US Patent 9,018,179",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5637597869281629686,2,2015
Methods and Compositions for RNAi Mediated Inhibition of Gene Expression in Mammals,"MA Kay, A McCaffrey","US Patent App. 13/941,262",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12251176354661479603,2,2013
A Species Restricted rAAV Vector Obtained from Viral Capsid Shuffling,"L Lisowski, K Chu, MA Kay","MOLECULAR THERAPY 21, S3-S3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11017045223481607775,2,2013
Simplified minicircle DNA vector production using genetically modified E. coli: towards a GMP suitable production process,"ZY Chen, CY He, MA Kay","MOLECULAR THERAPY 17, S286-S287",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5858556013108276115,2,2009
microRNAs outwit immune limitations in gene therapy,MA Kay,"Blood 110 (13), 4136-4137",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15185203208203574110,2,2007
11. Transposition from a Gene-Deleted Adenoviral Vector Results in Phenotypic Correction in a Canine Model for Hemophilia B,"A Ehrhardt, H Xu, AM Dillow, SR Yant, TC Nichols, MA Kay","Molecular Therapy 13, S5",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1556902303912360332,2,2006
1101. Fusion Proteins Consisting of the Sleeping Beauty Transposase and the Polydactyl Zinc Finger Protein E2C Direct Transposon Integration into a Unique Human Chromosomal …,"SR Yant, Y Huang, MA Kay","Molecular Therapy 11 (S1), S424",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17159486960319700293,2,2005
87. Determinants of Toxicity Induced by In Vivo Expression of Short Hairpin RNA from AAV Vectors,"D Grimm, KL Streetz, K Pandey, TA Storm, MA Kay","Molecular Therapy 11 (S1), S36",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3204804334101456176,2,2005
400. Successful Production of Pseudotyped Mosaic rAAV Vectors Using a Modified Baculovirus Expression System,"E Kohlbrenner, G Aslanidi, K Nash, S Shklayev, M Campbell-Thompson, ...","Molecular Therapy, 155",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6933947170842590873,2,2005
A model to quantitate cell transplant function after liver-specific injury,"DD Jenkins, K Streetz, MA Kay, MT Longaker, KG Sylvester","Journal of Surgical Research 114 (2), 305-306",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3896860032728703302,2,2003
Methods for delivery of genes to hepatocytes in vivo using recombinant adenovirus vectors,"D Barr, MA Kay","Gene Therapy Protocols, 205-212",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9200295136085020640,2,1997
Hepatic gene therapy for hemophilia B,MA Kay,"Inhibitors to Coagulation Factors, 229-234",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13846979619722494671,2,1995
Allele-specific silencing ameliorates restrictive cardiomyopathy due to a human myosin regulatory light chain mutation,"K Zaleta, A Dainis, AJS Ribeiro, P Sanchez-Cordero, G Rubio, C Shang, ...","bioRxiv, 559468",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2506785584732838613,1,2019
Targeted Integration of MUT into the Albumin Locus Using a Promoterless AAV Vector (Generide (TM)) Confers a Hepatocellular Growth Advantage in Mice with Methylmalonic Acidemia,"RJ Chandler, N Chau, K Chiang, MA Kay, A Barzel, CP Venditti","MOLECULAR THERAPY 26 (5), 446-447",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6909403254797221058,1,2018
"Circular nucleic acid vectors, and methods for making and using the same","MA Kay, ZY Chen","US Patent 9,745,590",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5880050381706870564,1,2017
Evolved AAV capsids for intramuscular passive vaccine administration to human skeletal muscle,"NK Paulk, K Pekrun, G Charville, K Maguire-Nguyen, J Xu, M Wosczyna, ...","MOLECULAR THERAPY 25 (5), 96-96",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9971814893155107383,1,2017
AAV capsid proteins for nucleic acid transfer,"L Lisowski, MA Kay","US Patent 9,169,299",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12183098940320915826,1,2015
262. Directed Evolution of Improved AAV Capsids for the Ideal Human Liver Vector–Can Human Liver Tropism and Human Immune Evasion Be Achieved?,"NK Paulk, K Pekrun, L Lisowski, Y Zhang, K Chu, MA Kay","Molecular Therapy 23, S104-S105",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10502505407860595186,1,2015
In vivo transduction with a chimeric AAV capsid protein,"M Kay, D Grimm","US Patent 8,906,387",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16708817185460724960,1,2014
Mini-intronic plasmid (MIP) vector sequences enhance AAV-mediated transgene expression in vitro and in vivo,"J Lu, J Williams, J Luke, F Zhang, MA Kay","MOLECULAR THERAPY 22, S112-S113",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17030263013561540893,1,2014
Cellular immune responses to vector in a gene therapy trial for hemophilia b using an AAV8 self-complementary factor IX vector,"F Mingozzi, Y Chen, A Nathwani, E Tuddenham, A Riddell, C Ng, ...","Blood 122 (21), 717-717",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9391847194914831061,1,2013
Stable factor IX activity following AAV-mediated gene transfer in patients with severe hemophilia B,"A Davidoff, EGD Tuddenham, S Rangarajan, C Rosales, J McIntosh, ...","Blood 120 (21), 752-752",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7514410674248803229,1,2012
"European Society of Gene and Cell Therapy French Society of Cell and Gene Therapy Collaborative Congress 2012 October 25–29, 2012 Palais des Congrès de Versailles Versailles …","T VandenDriessche, RA Pearson, RJ Chandler, CC Bartholomae, ...","Human Gene Therapy 23 (10), A1-A173",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13035520942100876405,1,2012
Cand45 tRNA-Derived Expression System for Gene Modulation,"MA Kay, D Haussecker","US Patent App. 13/265,429",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8358936344608600031,1,2012
A phase i/ii clinical trial entailing peripheral vein administration of a novel self complementary adeno-associated viral vector encoding human fix for haemophilia b gene therapy,"AC Nathwani, EGD Tuddenham, C Rosales, J Macintosh, P Chowdary, ...","MARY ANN LIEBERT INC 22 (6), A7-A8",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6710746969040878919,1,2011
Generation of Low-antigenicity MHC I Knock-down Human Embryonic Stem Cells Using Molecular Therapy,"T Deuse, M Seifert, N Phillips, A Fire, M Kay, P Tsao, H Reichenspurner, ...","Circulation 120 (suppl_18), S594-S595",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7893470173911725973,1,2009
The best of both worlds-integrating rAAV vectors as a safe tool for gene therapy,"L Lisowski, F Zhang, M Grompe, MA Kay","MOLECULAR THERAPY 17, S182-S182",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10198732746618368767,1,2009
489. Treatment for Hemophilia B Using Self-Complimentary AAV8 Vectors,"ML Hebert, D Grimm, TA Storm, MA Kay","Molecular Therapy 13, S189-S190","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8321608102494060029,13796788627715134194",1,2006
792. Post-Integrative Gene Silencing in the Sleeping Beauty Transposition System,"BS Garrison, SR Yant, JG Mikkelsen, MA Kay","Molecular Therapy 13, S307",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=837789893206962004,1,2006
1066. A Novel Class of Miniature Stabilized Double-Stranded AAV (msdsAAV) Vectors for the In Vivo Expression of Short Hairpin RNAs,"D Grimm, JS Lee, KL Streetz, TA Storm, MA Kay","Molecular Therapy 13, S409",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15898188229335164847,1,2006
389. Directed Transposon Integration in Human Cells,"SR Yant, Y Huang, B Akache, MA Kay","Molecular Therapy 13, S148-S149",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7554125985473069885,1,2006
804. In Vivo Correction of a Metabolic Liver Disease by AAV8-Mediated Homologous Recombination,"K Wursthorn, T Storm, MA Kay, M Finegold, M Grompe","Molecular Therapy 13, S311-S312",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2384115656067200495,1,2006
Cell therapy for hepatocyte replacement through bone marrow derived myelomonocytic progenitors,"KG Sylvester, D Jenkins, K Streetz, R Doyannis, S Perryman, M Kay, ...","Journal of the American College of Surgeons 201 (3), S47-S48",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15387925638106957686,1,2005
997. Loop Composition as Well as Orientation of the Guide Strand in shRNA May Dramatically Modulate Activity of the shRNA: Effect on the Development of RNAi-Based Inhibitors,"AA Kolykhalov, MW Graham, DA Suhy, PW Roelvink, AR Schroeder, ...","Molecular Therapy 11 (S1), S385",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7555125925493038045,1,2005
Allogeneic bone-marrow transplantation in mice provides tolerance and promotes massive in vivo selection of subsequently transplanted hepatocytes,"KL Streetz, R Doyonnas, D Jenkins, K Sylvester, MA Kay","JOURNAL OF HEPATOLOGY 42, 6-6",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10092607406813265139,1,2005
597. Liver Tissue Engineering at Extra-Hepatic Site: A Novel Therapeutic Approach toward Hemophilia,"K Ohashi, MA Kay, T Yokoyama, H Kuge, H Kanehiro, M Hisanaga, S Ko, ...","Molecular Therapy, 231",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13641401742848210723,1,2005
441. Short Hairpin RNA Interference Expressed from a Gene-Deleted Adenoviral Vector Results in Reduction of Hepatits B Surface Antigen Levels In Vitro and in a Small Animal …,"A Ehrhardt, H Xu, FH Salazar, PL Marion, MA Kay","Molecular Therapy, 171",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11376337593713599106,1,2005
Real-Time In Vivo Biodistribution of Multipotent Adult Progenitor Cells (MAPC): Role of the Immune System in MAPC Resistance in Non-Transplanted and Bone Marrow Transplanted Mice.,"J Tolar, S Bell, R McElmurry, L Xia, RS McIvor, SR Yant, MA Kay, ...","Blood 104 (11), 507-507",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18107170623644893647,1,2004
Development of a one-step column purification of minicircle vector DNA devoid of bacterial sequences that results in high level persistent transgene expression in vivo,"ZY Chen, CY He, MA Kay","MOLECULAR THERAPY 9, S54-S55",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17984531417121110057,1,2004
105. Optimization of Short-Hairpin RNAs for the Treatment of the Hepatitis C Virus Using AAV Vectors with Multiple Expression Cassettes,"PW Roelvink, DA Suhy, AA Kolykhalov, SM Cunningham, T Mizutani, ...","Molecular Therapy 9 (S1), S41",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14256283683255607090,1,2004
1014. Engineering Liver Tissues at the Kidney Capsule in Mice,"K Ohashi, Y Nakajima, MA Kay",Molecular Therapy 7 (5),https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3223687010463014755,1,2003
In vivo correction of FANCC mutant hematopoietic stem cells by DNA-mediated transposition,"M Noll, S Yant, JG Mikkelsen, RE Bennett, J Edington, C Chen, MA Kay, ...","MOLECULAR THERAPY 7 (5), S154-S154",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14933097011561292974,1,2003
The role of EBV and genomic sequences in gene expression from extrachromosomal gene therapy vectors in mouse liver,"SM Stoll, L Meuse, MA Kay, MP Calos","Gene Therapy and Molecular Biology 7, 211-219",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3022101730221719236,1,2003
Gene transfer for hemophilia and viral infection,MA Kay,"International Journal of Hematology 76 (1), 147-147",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12873473919307283997,1,2002
Pharmacologically regulated in vivo selection in a large animal.,"T Neff, PA Horn, C von Kalle, BL Wood, RE Richard, JC Morris, ...","Blood 98 (11), 817A-817A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14026123340597423307,1,2001
Mertk complements the phagocytosis defect of RCS retinal pigment epithelial cells in culture.,"W Feng, D Yasumura, PM D'Cruz, MT Matthes, M Kay, MM LaLail, ...","INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 42 (4), S761-S761",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18198899711328899697,1,2001
Correction of the retinal dystrophy phenotype of the RCS rat by adenovirus-mediated transfer of Mertk.,"D Vollrath, W Feng, D Yasumura, PM D'Cruz, MT Matthes, M Kay, ...","INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 42 (4), S125-S125",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16613371859943169924,1,2001
Persistent hF. IX expression in mouse hepatocytes from episomal rAAV circular intermediates does not rely on the presence of AAV-ITR but the structure of expression cassette …,"H Nakai, S Fuess, L Meuse, T Storm, MA Kay","Blood 96 (11), 431A-431A",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3550242712585210665,1,2000
AAV-mediated gene transfer for gemophilia B,M KAY,"Mol Ther 1, S3",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10187051138346212689,1,2000
Chromosomal abnormalities and schizophrenia: Further support for a putative schizophrenia susceptibility locus at 5q21-23.1.,"M Karayiorgou, RL Bennett, BL Galke, CA Sobin, M Kay","AMERICAN JOURNAL OF MEDICAL GENETICS 74 (6), 664-664",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3395059623225513587,1,1997
AAV vectors with expanded packaging capacity,"MA Kay, M Tiffany","US Patent 10,406,244",,0,2019
Allele-Specific Silencing Ameliorates Restrictive Cardiomyopathy Attributable to a Human Myosin Regulatory Light Chain Mutation,"K Zaleta-Rivera, A Dainis, AJS Ribeiro, P Cordero, G Rubio, C Shang, ...","Circulation 140 (9), 765-778",,0,2019
Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases,"A De Caneva, F Porro, G Bortolussi, R Sola, M Lisjak, A Barzel, M Giacca, ...",JCI insight,,0,2019
Elucidating the Mechanism of Species Specificity of Recombinant AAV Capsid Vector-Mediated Transduction,"S Tsuji, MA Kay","MOLECULAR THERAPY 27 (4), 220-221",,0,2019
Amino-Acylated LeuCAG3'tsRNA Mediates Translational Elongation of Ribosomal Protein S28 mRNA and is a Key Regulatory Step in Ribosome Biogenesis,"HK Kim, Z Liu, J Xu, K Chu, H Park, H Jang, P Li, P Valdmanis, Q Zhang, ...","MOLECULAR THERAPY 27 (4), 302-302",,0,2019
Transcriptional and Position Effect Contributions to rAAV-Mediated Gene Targeting,"LP Spector, M Tiffany, NM Ferraro, NS Abell, SB Montgomery, MA Kay","MOLECULAR THERAPY 27 (4), 294-294",,0,2019
Exploiting the Regenerative Capacity of Liver for Nuclease-Free Genome Editing,"F Puzzo, G De Alencastro, GA Patijn, F Zhang, K Pekrun, M Kay","MOLECULAR THERAPY 27 (4), 463-463",,0,2019
Treatment of Methylmalonic Acidemia by Targeted Integration of MUT into Albumin Using an Optimized Promoterless AAV Vector,"LE Venturoni, RJ Chandler, N Chau, J Liao, MA Kay, A Barzel, CP Venditti","MOLECULAR THERAPY 27 (4), 367-367",,0,2019
A Novel Adeno Associated Virus Capsid Variant selected on Human Islets Shows Robust Transduction in Many Cell Types In Vitro and In Vivo,"K Pekrun, G De Alencastro, F Galivo, Y Kim, F Zhang, R Song, M Tiffany, ...","MOLECULAR THERAPY 27 (4), 25-26",,0,2019
Efficient and Long-Term Correction of Liver Metabolic Diseases by Coupling AAV-Mediated Promoterless Gene Targeting to SaCas9 Nuclease,"A De Caneva, F Porro, G Bortolussi, R Sola, M Lisjak, A Barzel, M Giacca, ...","MOLECULAR THERAPY 27 (4), 461-461",,0,2019
Methods and compositions for facilitating homologous recombination,"MA Kay, G De Alencastro","US Patent App. 16/024,324",,0,2019
Using a barcoded AAV capsid library to select for novel clinically relevant gene therapy vectors,"K Pekrun, G De Alencastro, QJ Luo, J Liu, Y Kim, S Nygaard, F Galivo, ...","bioRxiv, 683672",,0,2019
Targeted integration of MUT into Albumin using a promoterless AAV vector (GeneRide (TM)) confers a hepatocellular growth advantage in mice with methylmalonic acidemia (MMA),"RJ Chandler, N Chau, J Liao, L Venturoni, MA Kay, A Barzel, CP Venditti","HUMAN GENE THERAPY 29 (12), A126-A126",,0,2018
"Changing the Face of Modern Medicine: Stem Cell and Gene Therapy Organized Jointly by the European Society of Gene & Cell Therapy (ESGCT), International Society for Stem Cell …","KM Champion, P Albertini, I Visigalli, F Cecere, N Carriglio, ...","Human Gene Therapy 29 (12), A1-A169",,0,2018
Aav capsid proteins for nucleic acid transfer,"L Lisowski, MA Kay","US Patent App. 15/829,639",,0,2018
Non-silencing selectable marker genes and methods of use,"MA Kay, J Lu","US Patent App. 15/969,478",,0,2018
Abstract IA03: Functional lung cancer genomics through in vivo genome editing,"IP Winters, ZN Rogers, CD McFarland, PV Lalgudi, SH Chiou, MA Kay, ...","Clinical Cancer Research 24 (17 Supplement), IA03-IA03",,0,2018
Abstract LB-390: A transfer RNA derived small RNA affects translation in rapidly dividing cells and a target for hepatocellular carcinoma,"HK Kim, G Fuchs, S Wang, W Wei, Y Zhang, H Park, B Roy-Chaudhuri, ...","Cancer Research 78 (13 Supplement), LB-390-LB-390",,0,2018
Novel recombinant adeno-associated virus capsids containing a designed ankyrin repeat protein (darpin) or fragment thereof,"MA Kay, RC Muench","US Patent App. 15/838,222",,0,2018
Transcriptional and Position Effect Contributions to rAAV-Mediated Homologous Recombination,"LP Spector, M Tiffany, MA Kay","MOLECULAR THERAPY 26 (5), 368-368",,0,2018
Promoterless Targeting without Nucleases of Hyperactive Factor IX Corrects the Bleeding Diathesis in Hemophilia B Mice,"Y Hayon, N Reines, I Kilovaty, Y Rais, N Chau, K Chiang, L Lisowski, ...","MOLECULAR THERAPY 26 (5), 89-90",,0,2018
Disruption of the Heparin-Binding Site and Insertion of the PHB. P Peptide in AAV-DJ Improve Transduction of the Central Nervous System,"R Song, MA Kay","MOLECULAR THERAPY 26 (5), 40-41",,0,2018
Alteration of AAV Capsid Lumenal Residues to Expand Vector Genome Packaging Capacity,"M Tiffany, K Pekrun, F Zhang, MA Kay","MOLECULAR THERAPY 26 (5), 191-191",,0,2018
Improved Genome Editing through Inhibition of the FANCM Pathway,"G de Alencastro, K Pekrun, F Zhang, S Pillay, K Majzoub, J Carette, ...","MOLECULAR THERAPY 26 (5), 433-434",,0,2018
"Generide (TM), a Novel AAV Strategy to Treat Pediatric Patients with Methylmalonic Acidemia","J Liao, Y Rais, Y Hayon, A Barzel, L Lisowski, MA Kay, K Chiang, N Chau","MOLECULAR THERAPY 26 (5), 363-363",,0,2018
CORRECTION OF MURINE MODELS OF METHYLMALONIC ACIDEMIA USING ALBUMIN TARGETED HOMOLOGOUS RECOMBINATION WITH A PROMOTERLESS ADENO-ASSOCIATED VIRAL INTEGRATING VECTOR,"RJ Chandlers, A Cahana, MA Kay, A Barzel, CP Venditti","MOLECULAR GENETICS AND METABOLISM 123 (3), 206-206",,0,2018
"Self-complementary parvoviral vectors, and methods for making and using the same","MA Kay, D Grimm","US Patent App. 15/706,283",,0,2018
"Circular nucleic acid vectors, and methods for making and using the same","MA Kay, ZY Chen","US Patent App. 15/653,209",,0,2018
AAV capsid proteins for nucleic acid transfer,"L Lisowski, MA Kay","US Patent 9,856,469",,0,2018
Whole-body correction of Pompe disease by AAV liver-mediated gene transfer of engineered secretable GAA transgenes,"F Puzzo, P Colella, MG Biferi, D Bali, NK Paulk, P Vidal, F Collaud, ...","HUMAN GENE THERAPY 28 (12), A12-A12",,0,2017
GeneRide (TM): Therapeutic In vivo gene targeting without nucleases,"Y Hayon, A Cohen-Fredarow, A Cahana, N Reines, L Lumerman, ...","HUMAN GENE THERAPY 28 (12), A52-A53",,0,2017
"ESGCT XXV Anniversary Congress in Collaboration with the German Society for Gene Therapy October 17–20, 2017 Berlin, Germany","SM Maffioletti, S Sarcar, A Henderson, I Mannhardt, L Pinton, LA Moyle, ...","Human Gene Therapy 28 (12), A1-A125",,0,2017
Human and Baculovirus-Insect Manufacturing Platforms Generate Chemically and Functionally Distinct AAV Vectors with Sexually Dimorphic Liver Transduction.,"NK Paulk, N Rumachik, S Malaker, C Adams, R Leib, CR Bertozzi, M Kay","HEPATOLOGY 66, 373A-373A",,0,2017
Non-disruptive gene targeting,"MA Kay, M Porteus, J Barker, J Checketts, R Voit, A Barzel","US Patent App. 15/457,923",,0,2017
Nucleosome-excluding sequences (NES) as a DNA spacer in vectors results in prolonged transgene expression in eukaryotic cells,"J Lu, MA Kay, A Fire, LEG Maniar","US Patent 9,701,981",,0,2017
CRISPR/Cas9 sgRNAs Do Not Exert the Same Competition with Liver microRNAs as shRNAs,"PN Valdmanis, K Chu, F Zhang, Q Luo, MA Kay","MOLECULAR THERAPY 25 (5), 296-296",,0,2017
Small Hairpin RNAs Delivered in Human Cortical Spheroids Compete with Endogenous microRNAs,"PN Valdmanis, J Andersen, K Chu, SP Pasca, MA Kay","MOLECULAR THERAPY 25 (5), 37-37",,0,2017
Transcriptional and Position Effect Contributions to rAAV-Mediated Homologous Recombination,"LP Spector, M Tiffany, MA Kay","MOLECULAR THERAPY 25 (5), 84-85",,0,2017
A 3'tRNA Derived Small RNA (tsRNA) Affects Translation in Rapidly Dividing Cells and a Target for Hepatocellular Carcinoma,"H Kim, G Fuchs, S Wang, W Wei, Y Zhang, H Park, B Roy-Chaudhuri, ...","MOLECULAR THERAPY 25 (5), 34-35",,0,2017
Tracking Adeno-Associated Virus (AAV) Capsid Evolution by High-Throughput Sequencing,"G de Alencastro, K Pekrun, PN Valdmanis, J Xu, MA Kay","MOLECULAR THERAPY 25 (5), 44-45",,0,2017
Proof-of-Concept for Non-Nuclease-Mediated Genome Editing to Treat A-1 Antitrypsin Deficiency,"F Borel, A Barzel, MA Kay, C Mueller","MOLECULAR THERAPY 25 (5), 29-30",,0,2017
Alteration of AAV Capsid Lumenal Residues Expands Genome Packaging Capacity,"MR Tiffany, K Pekrun, F Zhang, MA Kay","MOLECULAR THERAPY 25 (5), 47-47",,0,2017
Liver-Mediated Gene Therapy with an Engineered Secretable GAA Transgene Results in Whole-Body Correction of Pompe Disease,"G Ronzitti, P Colella, F Puzzo, MG Biferi, D Bali, NK Paulk, P Vidal, ...","MOLECULAR THERAPY 25 (5), 244-244",,0,2017
"Rescue of Mice with Methylmalonic Acidemia from Immediate Neonatal Lethality Using an Albumin Targeted, Promoterless Adeno-Associated Viral Integrating Vector","RJ Chandler, A Cahana, BT Hubbard, MA Kay, A Barzel, CP Venditti","MOLECULAR THERAPY 25 (5), 13-13",,0,2017
Genome Editing without Nucleases,"A Barzel, MA Kay","US Patent App. 15/126,860",,0,2017
tRNA DERIVED SMALL RNAs (tsRNAs) INVOLVED IN CELL VIABILITY,"MA Kay, HK Kim, S Wang","US Patent App. 15/216,546",,0,2017
EFFECTS OF A STRUCTURED EXERCISE PROGRAM ON PHYSICAL ACTIVITY AND FITNESS IN COLON CANCER SURVIVORS: 1-YEAR FEASIBILITY RESULTS FROM THE CHALLENGE TRIAL AND STUDY UPDATE,"J Vardy, M Kay, J Turner, K Gunningham, K Courneya, C Callaghan, ...","ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 12, 79-80",,0,2016
Novel antibiotic-free vectors for gene therapy and DNA vaccination,"J Lu, J Luke, MA Kay, JA Williams","HUMAN GENE THERAPY 27 (11), A105-A106",,0,2016
Making a good vector even better: novel rAAVs for classical gene therapy and genome editing,MA Kay,"HUMAN GENE THERAPY 27 (11), A22-A22",,0,2016
"Changing the Face of Modern Medicine: Stem Cells and Gene Therapy Florence, Italy October 18–21, 2016 Abstracts","JC Ramírez, AB del Campo, A Pañeda, I Jiménez, A Berlanga, A Mork, ...","Human Gene Therapy 27 (11), A1-A185",,0,2016
Non-silencing selectable marker genes and methods of use,"MA Kay, J Lu","US Patent App. 15/019,838",,0,2016
"Dieter C. Gruenert, PhD (1949–2016)","P Disterer, MA Kay, GC Parker","Nucleic acid therapeutics 26 (4), 266-267",,0,2016
AAV vectors: making something good even better,M Kay,"HUMAN GENE THERAPY 27 (7), A3-A3",,0,2016
British Society for Gene and Cell Therapy Annual Conference University College London Institute of Child Health Friday 15th April 2016 Conference Abstracts,"F Mingozzi, H Büning, I Trapani, A Auricchio, M Rizzi, A Jenkins, M Kay, ...","Human Gene Therapy 27 (7), A1-A20",,0,2016
Sequence Modified Antibiotic Resistance Genes Provide Sustained Plasmid Mediated Transgene Expression in Mammals,"J Lu, F Zhang, A Fire, M Kay","MOLECULAR THERAPY 24, S116-S116",,0,2016
737. RNAi Induced Hepatotoxicity Results from a Functional Depletion of the First Synthesized Isoform of miR-122,"PN Valdmanis, S Gu, K Chu, L Jin, F Zhang, EM Munding, Y Zhang, ...","Molecular Therapy 24, S290-S291",,0,2016
129. Does Transcription Influence AAV-Mediated Homologous Recombination?,"LP Spector, MA Kay","Molecular Therapy 24, S53",,0,2016
539. Screening for Recombinant Adeno-Associated Viral Vectors That Selectively Transduce Hepatitis B Virus Infected Cells,"G de Alencastro, K Pekrun, M Kay","Molecular Therapy 24, S215",,0,2016
48. Treatment of Methylmalonic Acidemia by Promoterless Gene-Targeting Using Adeno-Associated Viral (AAV) Mediated Homologous Recombination,"RJ Chandler, A Barzel, MA Kay, CP Venditti","Molecular Therapy 24, S21-S22",,0,2016
722. AAV Capsid Evolution for Enhanced Antibody Delivery to Human Skeletal Muscle for Use in Next-Generation HIV Vaccines and Muscle Gene Therapies,"NK Paulk, G Charville, K Maguire, K Pekrun, Y Zhang, M Tiffany, ...","Molecular Therapy 24, S284-S285",,0,2016
257. Selection of Next Generation AAV Gene Therapy Vectors for Specific and Precise Gene Delivery,"R Muench, M Kay","Molecular Therapy 24, S101",,0,2016
A Tribute to George Stamatoyannopoulos,"A Srivastava, MA Kay, T Athanasopoulos, M Angastiniotis, ...","Human gene therapy 27 (4), 280-286",,0,2016
Compositions and methods for modulating activity of capped small RNAS,"MA Kay, D Haussecker, D Cao","US Patent 9,255,300",,0,2016
KEYNOTE SPEAKER 7: NEW RAAV VECTORS AND APPROACHES FOR EPISOMAL AND INTEGRATION BASED GENE TRANSFER,M Kay,The Journal of Gene Medicine 17 (8-9),,0,2015
156. Cationic Lipopolymers for BCR-ABL siRNA Delivery and Growth Arrest in Chronic Myeloid Leukemia Tumors,"J Valencia-Serna, KCB Remant, X Yang, HM Aliabadi, MB Parmar, ...","Molecular Therapy 23, S62-S63",,0,2015
683. In Vivo Expansion of Hepatocytes with Targeted rAAV Integration Results in a> 100-Fold Increase of Transgene Expression,"S Nygaard, A Barzel, A Haft, MA Kay, M Grompe","Molecular Therapy 23, S272",,0,2015
94. AAV Integration Site Determination Using Illumina Mate Pair Sequencing,"MR Tiffany, MA Kay","Molecular Therapy 23, S39-S40",,0,2015
578. microRNA Inhibition Through Gapmer Activated RNase H-Mediated Degradation,"EM Munding, MA Kay","Molecular Therapy 23, S230",,0,2015
305. A Screening Strategy for Selecting Recombinant Adeno-Associated Viral Vectors That Selectively Transduce Viral Infected Cells,"G de Alencastro, NK Paulk, K Pekrun, MA Kay","Molecular Therapy 23, S123",,0,2015
303. AAV Capsid Evolution for Enhanced Antibody Delivery To Human Muscle for Use in Next-Generation HIV Vaccines,"NK Paulk, GW Charville, K Pekrun, K Maguire, TA Rando, MA Kay","Molecular Therapy 23, S122-S123",,0,2015
688. AAV8-Mediated Liver Gene Targeting Without Nucleases Rescues Lethality in a Mouse Model of the Crigler-Najjar Syndrome,"F Porro, G Bortolussi, A Barzel, L Zentilin, S Vodret, L Bockor, MA Kay, ...","Molecular Therapy 23, S274",,0,2015
In vivo transduction with a chimeric aav capsid protein,"M Kay, D Grimm","US Patent App. 14/537,035",,0,2015
Method of making induced pluripotent stem cell from adipose stem cells using minicircle DNA vectors,"J Wu, MT Longaker, MA Kay, N Sung, FJ Jia, ZY Chen, N Panetta, ...","US Patent 8,962,331",,0,2015
Erratum: Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa (Science Translational Medicine (2014) 6 (267er8)),"V Sebastiano, HH Zhen, B Haddad, E Bashkirova, SP Melo, P Wang, ...","Science Translational Medicine 6 (267), 267er8",,0,2014
Novel rAAV vectors for episomal and integration based gene transfer,MA Kay,"HUMAN GENE THERAPY 25 (11), A16-A16",,0,2014
ESGCT and NVGCT Collaborative Congress: The Hague-23 to 26 October Abstracts,"E Vroom, A Aartsma-Rus, RC Hoeben, H Büning, H Abken, M Pegtel, ...","Human Gene Therapy 25 (11), A1-A121",,0,2014
Weak base pairing in both seed and 3'regions reduces RNAi off-targets and enhances si/shRNA designs,"M Kampmann, S Gu, Y Zhang, L Jin, Y Huang, F Zhang, MC Bassik, ...",,,0,2014
tRNA derived small RNAs (tsRNAs) involved in cell viability,"MA Kay, HK Kim, W Shengchun",,,0,2014
"Circular nucleic acid vectors, and methods for making and using the same","MA Kay, ZY Chen","US Patent 8,828,726",,0,2014
Utilizing DNA Shuffling Technologies To Generate AAV Libraries To Select for and Evolve Capsids With an Expanded Packaging Capacity,"N Paulk, K Pekrun, M Kay","MOLECULAR THERAPY 22, S116-S117",,0,2014
Precursor microRNA Can Act as a Post-Transcriptional Regulator of Mature microRNA Activity,"B Roy-Chaudhuri, PN Valdmanis, Y Zhang, Q Wang, Q Luo, MA Kay","MOLECULAR THERAPY 22, S5-S5",,0,2014
The Linkage of Backbone Transcription and Plasmid DNA Silencing,"J Lu, F Zhang, LEG Maniar, W Zhang, A Fire, MA Kay","MOLECULAR THERAPY 22, S4-S4",,0,2014
In vivo Gene-Targeting Without Nucleases Facilitates Therapeutic Levels of hF-IX Following AAV8 Vector Injections of Either Neonate or Adult Mice,"A Barzel, NK Paulk, Y Shi, Y Huang, K Chu, F Zhang, MH Porteus, ...","MOLECULAR THERAPY 22, S89-S89",,0,2014
Evaluating Competition of Delivered Small Hairpin RNAs with Endogenous microRNAs for Safe Effective Gene Knockdown,"PN Valdmanis, S Gu, L Lisowski, L Jin, K Chu, F Zhang, Y Huang, MA Kay","MOLECULAR THERAPY 22, S208-S208",,0,2014
AAV-Mediated Direct Somatic Genetic Correction of Epidermolysis Bullosa,"S Melo, L Lisowski, L Bashkirova, MA Kay, AE Oro","MOLECULAR THERAPY 21, S106-S106",,0,2013
Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP),"A Barzel, MA Kay","MOLECULAR THERAPY 21, S132-S133",,0,2013
Upregulation of a Cluster of microRNAs on Mouse Chromosome 12qF1 in a Kras Mutant Mouse Model of Lung Adenocarcinoma,"PN Valdmanis, B Roy-Chaudhuri, HK Kim, LC Sayles, Y Zheng, ...","MOLECULAR THERAPY 21, S168-S168",,0,2013
Use on minicircle vectors for cardiac gene therapy,"J Wu, MA Kay, M Huang, ZY Chen","US Patent 8,445,454",,0,2013
AAV-mediated somatic genetic correction of epidermolysis bullosa,"SP Melo, L Lisowski, L Bashkirova, MA Kay, AE Oro","JOURNAL OF INVESTIGATIVE DERMATOLOGY 133, S139-S139",,0,2013
The Extragenic Spacer Length Between the 5 [variant prime] and 3 [variant prime] Ends of the Transgene Expression Cassette Affects Transgene Silencing From Plasmid-based Vectors,"J Lu, F Zhang, S Xu, AZ Fire, MA Kay","Molecular Therapy 20 (11), 2111",,0,2012
Optimization of liver gene transfer for hemophilia B,"XM Anguela, Y Chen, RJ Davidson, S Zhou, TC Nichols, MA Kay, ...","HUMAN GENE THERAPY 23 (10), A53-A53",,0,2012
DNA Vector Development & Gene Targeting III,"A Barzel, R Voit, M Porteus, MA Kay","Molecular Therapy 20, 1",,0,2012
"Novel, Shuffled, Human-Specific rAAV Vectors","L Lisowski, K Chu, MA Kay","MOLECULAR THERAPY 20, S140-S141",,0,2012
Targeting 2A-Fusions to Endogenous Genes,"A Barzel, R Voit, M Porteus, MA Kay","MOLECULAR THERAPY 20, S234-S234",,0,2012
Effect of Argonaute-2 in Mediating Non-Coding RNA Expression,"PN Valdmanis, BR Chaudhuri, D Cao, Y Pouliot, MA Kay","MOLECULAR THERAPY 20, S133-S133",,0,2012
"Circular nucleic acid vectors, and methods for making and using the same","MA Kay, ZY Chen","US Patent 8,124,407",,0,2012
Immunobiology of naïve and genetically-modified HLA I knockdown human embryonic stem cells,"T Deuse, M Seifert, N Phillips, A Fire, D Tyan, M Kay, PS Tsao, X Hua, ...","The Thoracic and Cardiovascular Surgeon 60 (S 01), V141",,0,2012
Compositions and methods for modulating activity of capped small RNAs,"MA Kay, D Haussecker, D Cao","US Patent 8,034,922",,0,2011
"AACR 2011 Annual Meeting, Abs. LB-409","A Aartsma-Rus, C de Winter, M van Putten, T Karnaoek, J van Deutekom, ...","nucleic acid therapeutics 21 (5), A1-A64",,0,2011
THE MECHANISM OF miRNA AND siRNA ARGONAUTE LOADING IN MAMMALS,"MA Kay, S Gu, L Jin","NUCLEIC ACID THERAPEUTICS 21 (5), A50-A51",,0,2011
"European Society of Gene and Cell Therapy British Society for Gene Therapy Collaborative Congress 2011 October 27–31, 2011 The Brighton Centre, Brighton United Kingdom","LW Seymour, M Antoniou, DRP Harbottle, C Denning, R Hajjar, S Ferber, ...","Human Gene Therapy 22 (10), A1-A138",,0,2011
Dose-dependent activation of capsid-specific T cells after AAV serotype 8 vector administration in a clinical study for hemophilia B,"F Mingozzi, E Basner-Tschakarjan, Y Chen, AC Nathwani, ...","Journal of Thrombosis and Haemostasis 9, 761-762",,0,2011
NOVEL ANTI-HCV THERAPY: SINGLE SHRNA TARGETING BOTH STRANDS OF HCV,"L Lisowski, M Elazar, K Chu, JS Glenn, MA Kay","JOURNAL OF GENE MEDICINE 13 (7-8), 418-419",,0,2011
Enhanced transgene expression improves immune responses following DNA vaccination (53.1),"N Skinner, W Dietz, M Jund, P Hwu, ZY Chen, M Kay, B Blazar, C Pennell, ...","The Journal of Immunology 186 (1 Supplement), 53.1-53.1",,0,2011
547 Hypoimmunogeneic HLA I Knockdown Human Embryonic Stem Cells Induce Host Ignorance and Achieve Prolonged Xenogeneic Survival,"T Deuse, M Seifert, A Fire, N Phillips, X Hua, J Velden, M Kay, HD Volk, ...","The Journal of Heart and Lung Transplantation 30 (4), S184",,0,2011
Generation of genetically engineered low-antigenicity MHC I knock-down human embryonic stem cells to prevent immune rejection,"T Deuse, M Seifert, A Fire, N Philipps, X Hua, J Velden, M Kay, D Volk, ...","The Thoracic and Cardiovascular Surgeon 59 (S 01), V156",,0,2011
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield.,"Y Qiu, B Yang, X Lan, XR Li, XP Yin, JX Liu, M Azat, T Hiroyuki, ...","Asian Journal of Animal and Veterinary Advances 7 (12), 204-209",,0,2011
ESGCT 2010 Oral Presentations,"T Cathomen, T VandenDriessche","HUMAN GENE THERAPY 21, 1358-1396",,0,2010
IMMUNOGENICITY OF MESENCHYMAL STEM CELLS FROM THE UMBILICAL CORD LINE FOR REGENERATIVE THERAPIES: 0085,"M Stubbendorff, K Tang-Quan, T Deuse, N Philipp, M Kay, R Robbins, ...",Transplant International 23,,0,2010
Comparison of minicircle production methods for delivering naked DNA and expressing genes in animals,"HM Viecelli, ZY Chen, MA Kay, RP Harbottle, B Thony","HUMAN GENE THERAPY 21 (10), 1450-1450",,0,2010
"Gene Transfer Approaches for Gene Addition, Knockdown and Cellular Reprogramming In Vivo",MA Kay,"HUMAN GENE THERAPY 21 (9), 1172-1173",,0,2010
DNA Vectorology & Gene Targeting,"LE Gracey, ZY Chen, JM Maniar, A Valouev, A Sidow, AZ Fire, MA Kay","Molecular Therapy 18, 1",,0,2010
Gene transfer to induce cellular reprogramming for the treatment of diabetes,"N Phillips, M Grompe, MA Kay","HUMAN GENE THERAPY 21 (5), 642-643",,0,2010
128: Immunogenicity of Fetal Mesenchymal Stem Cells from the Umbilical Cord Line for Regenerative Therapies,"KR Tang-Quan, MVV Kolk, T Deuse, N Philipp, M Kay, RC Robbins, ...","The Journal of Heart and Lung Transplantation 29 (2), S48",,0,2010
347: Generation of Genetically Engineered Low-Antigenicity MHC I Knock-Down Human Embryonic Stem Cells To Prevent Immune Rejection,"T Deuse, M Seifert, A Fire, N Phillips, M Kay, H Reichenspurner, ...","The Journal of Heart and Lung Transplantation 29 (2), S116-S117",,0,2010
Early clinical trial results following administration of a low dose of a novel self complementary adenohyphen; associated viral vector encoding human factor ix in two subjects …,"AC Nathwani, EGD Tuddenham, C Rosales, J McIntosh, A Riddell, ...","MARY ANN LIEBERT INC 21 (10), 1362-1362",,0,2010
Enhancing HIF-1a by Double shRNA Knockdown in Murine Myocardial Infarction,"M Huang, F Jia, S Hu, X Wang, MA Kay, RC Robbins, JC Wu","Circulation 120 (suppl_18), S827-S828",,0,2009
FACING THE BLEEDING OBVIOUS: AAV-MEDIATED GENE THERAPY FOR HAEMOPHILIA B,"J Rasko, K High, M Tigges, C Manno, D Sabatino, M Dake, J McDonnell, ...",The Journal of Gene Medicine 11 (9),,0,2009
910. Gene Transfer to Mouse Heart–A Study of Mini-Circle Vector Efficiency,"S Stenler, A Andersson, OE Simonson, KE Lundin, ZY Chen, MA Kay, ...","Molecular Therapy 17, 1",,0,2009
The D4Z4 Insulator Protects Retrovirus Vectors from Silencing in Stem Cells,"S Rival-Gervier, J Ellis","MOLECULAR THERAPY 17, S172-S172",,0,2009
A Hyperactive Transposase System Delivered by a High-Capacity Adenoviral Vector Results in Long-Term Phenotypic Correction of Canine Hemophilia B,"MA Hausl, W Zhang, HW Franck, TC Nichols, MA Kay, A Ehrhardt","MOLECULAR THERAPY 17, S241-S242",,0,2009
AAV-rDNA Mediated Site-Specifi c Integration in Human Cell and Safety Analysis in Long-Term AAV-rDNA Treated Mice,"Z Wang, J Mathur, L Lisowski, M Kay, M Grompe","MOLECULAR THERAPY 17, S174-S174",,0,2009
The Mechanism (s) Responsible for Plasmid DNA Silencing In Vivo,"J Lu, ZY Chen, MA Kay","MOLECULAR THERAPY 17, S285-S286",,0,2009
Hepatic Reprogramming for Treatment of Diabetes Requires a Host Response to Vector,"N Phillips, MA Kay","MOLECULAR THERAPY 17, S296-S297",,0,2009
AAV Based RNAi Therapies To Treat and/or Prevent HCV in Animal Models,"L Lisowski, M Elazar, M Grompe, JS Glenn, MA Kay","MOLECULAR THERAPY 17, S14-S14",,0,2009
Gene Transfer to Mouse Heart-A Study of Mini-Circle Vector Efficiency,"S Stenler, A Andersson, OE Simonson, KE Lundin, ZY Chen, MA Kay, ...","MOLECULAR THERAPY 17, S348-S348",,0,2009
Wandering eye for RNAi,MA Kay,"Nature Medicine 14 (6), 611",,0,2008
494. An Effort To Create a Factor IX Expression Vector That Promotes Sustained Gene Expression through the Placement of Nucleosome Positioning Signals,"LE Gracey, ZY Chen, WO Lui, AZ Fire, MA Kay","Molecular Therapy 16, 1",,0,2008
In Vitro and In Vivo Gene Therapy Vector,"TAS Akache, MA Kay","J. Virol 82 (12), 5887",,0,2008
Minicircle Plasmid Containing the Human Manganese Superoxide Dismutase (MnSOD) Transgene Confers Radioprotection to Hematopoietic Progenitor Cell Line 32Dcl3.,"X Zhang, MW Epperly, MA Kay, ZY Chen, T Smith, D Franicola, ...","Blood 110 (11), 5138-5138",,0,2007
A Minicircle Plasmid Containing the Human Manganese Superoxide Dismutase (MnSOD) Transgene Confers Radioprotection to Cells InVitro,"X Zhang, MW Epperly, MA Kay, Z Chen, T Smith, D Franicola, ...","International Journal of Radiation Oncology• Biology• Physics 69 (3), S625",,0,2007
Liver directed AAV-mediated homologous recombination is largely independent of serotype,"K Wursthorn, N Paulk, T Storm, MJ Finegold, M Kay, M Grompe","HEPATOLOGY 46 (4), 887A-887A",,0,2007
"DNA palindromes with a modest arm length of≧∼ 20 bp are a significant target for rAAV vector integration in the liver, muscle and heart in mice","K Inagaki, SM Lewis, X Wu, C Ma, DJ Munroe, S Fuess, TA Storm, MA Kay, ...",Journal of Virology,,0,2007
Dual system of RNA trans-splicing element and sleeping beauty transposon corrects dna protein kinase mutation in severe combined immune deficiency,"J Tolar, H Zayed, L Xia, A Yerich, SR Yant, MA Kay, M Puttaraju, ...","HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 92, 154-154",,0,2007
DNA palindromes are a prevalent and significant source of DNA breaks in the mammalian genome,"K Inagaki, S Lewis, X Wu, D Munroe, S Fuess, T Storm, M Kay, H Nakai","Cancer Research 67 (9 Supplement), 1108-1108",,0,2007
Reviewer 1,M Kay,"HUMAN GENE THERAPY 3, 27-2006",,0,2007
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Commentary,"MA KAY, BD BROWN, A CANTORE, A ANNONI, L SERGI SERGI, ...",Blood 110 (13),,0,2007
AAV8 vector injection at birth significantly augments the progression of liver tumors in HBV transgenic mice predisposed to hepatocellular carcinoma,"K Inagaki, SPS Monga, TA Storm, S Fuess, MA Kay, H Nakai","JOURNAL OF GENE MEDICINE 8 (12), 1445-1446",,0,2006
Osteosarcoma Derived from Cultured Mesenchymal Stem Cells.,"J Tolar, AJ Nauta, MJ Osborn, A Panoskaltsis-Mortari, RT McElmurry, ...","Blood 108 (11), 2554-2554",,0,2006
Correction of severe combined immune deficiency in multipotent adult progenitor cells by spliceosome-mediated RNA trans-splicing and Sleeping Beauty transposon delivery,"H Zayed, L Xia, A Yerich, SR Yant, MA Kay, M Puttaraju, G Mansfield, ...","EXPERIMENTAL HEMATOLOGY 34 (9), 49-49",,0,2006
In vivo selection of liver cells in a model of allogeneic bone-marrow-transplantation,"K Streetz, R Doyonnas, D Jenkins, S Perryman, S Lin, C Trautwein, ...","Zeitschrift für Gastroenterologie 44 (08), V02",,0,2006
ADENOVIRUS VECTORS: HYBRID VECTORS/NOVEL SEROTYPES/TARGETING,"A Ehrhardt, H Xu, AM Dillow, SR Yant, TC Nichols, MA Kay","Molecular Therapy 13, 1",,0,2006
538. DNAvaletTM Transfection Reagent,"E Riu, ZY Chen, MA Kay","Molecular Therapy 13, 1",,0,2006
Rapid and Stable Knockdown of the Endogenous Neuroprotective Factor bFGF in the Retina in vivo Using Viral Vectors,"DM Paskowitz, KP Greenberg, D Yasumura, D Grimm, MA Kay, ...","Investigative Ophthalmology & Visual Science 47 (13), 4826-4826",,0,2006
538. DNAvaletTM Transfection Reagent,C Prata,"Molecular Therapy 13 (S1), S207",,0,2006
539. Unraveling the Mechanisms Underlying Silencing/Activation of Episomal Vectors In Vivo,"E Riu, ZY Chen, MA Kay","Molecular Therapy 13 (S1), S207",,0,2006
531. Complexes of DNA-Cationic Liposomes with Baculovirus GP64 Envelope Fusion Protein Vesicles Demonstrate Enhanced Transfection Efficiency,"GH Guibinga, S Song, J Loring, T Friedmann","Molecular Therapy 13 (S1), S204",,0,2006
75 In vivo selection of primary and bone-marrowderived hepatocytes after allogeneic transplantation in mice,"KL Streetz, R Doyonnas, D Jenkins, S Perryman, S Fuess, S Lin, ...","Journal of Hepatology 44, S33",,0,2006
Analysis of vector genome integration sites in various tissues following systemic administration of AAV serotype 8 vector in mice,"K Inagaki, XL Wu, S Fuess, TA Storm, MA Kay, H Nakai","JOURNAL OF GENE MEDICINE 8 (3), 391-391",,0,2006
Fatality in Mice Due to Oversaturation of Cellular Micro/Short Hairpin RNA Pathways,"D Grimm, KL Streetz, TA Storm, CL Jopling, JS Lee, MA Kay","Molecular Therapy, S312",,0,2006
852. Chromatin Study of Adenovirus Vector DNA In Vivo,"D Cao, MA Kay","Molecular Therapy 13, S329",,0,2006
20. Construction and Characterization of Adenovirus Vectors Expressing Optimized Blood Stage Antigens of Plasmodium falciparum,"P Chen, S Konovalova, K Limbach, ME Stefaniak, NB Patterson, ...","Molecular Therapy 13, S8-S9",,0,2006
103. A Screen for Host Cellular Proteins That Interact with Adeno-Associated Virus Capsid Proteins Reveals Proteins Involved in AAV8 Transduction,"B Akache, S Fuess, D Grimm, MA Kay","Molecular Therapy 13, S42-S43",,0,2006
108. Study of an AAV-8 Capsid Mutant with Direct Heparin Binding Capability but Reduced Efficiency in Liver-Targeted Transduction,"X Shen, H Xu, T Storm, MA Kay","Molecular Therapy 13, S44-S45",,0,2006
746. Localization of Structural Determinants in AAV Capsid for Efficient Liver Transduction by Domain Swapping between AAV-2 and AAV-8,"X Shen, H Xu, T Storm, MA Kay","Molecular Therapy 13, S288",,0,2006
9. Biology of rAAV8 in Mouse Liver Following Vector Administration at Birth,"K Inagaki, S Fuess, TA Storm, MA Kay, H Nakai","Molecular Therapy 13, S4",,0,2006
1034. Expression of Short Hairpin RNAs by Liver and Non Liver Specific RNA Pol II Expression Cassettes: What Governs Activity?,"DA Suhy, AA Kolykhalov, LB Couto, LM Garcia, AR Schroeder, AE Parker, ...","Molecular Therapy 13, S397",,0,2006
796. Pol II-Driven shRNA as an Effective Hepatitis B Virus Therapeutic,"JC Giering, D Grimm, TA Storm, H Xu, MA Kay","Molecular Therapy 13, S308-S309",,0,2006
680. Non-Viral Transposon Mediated Gene Transfer of Human Factor VIII to Hemophilia A Mice,"L Xie, Y Kang, S Yant, M Kay, P McCray","Molecular Therapy 13, S262",,0,2006
115. Whole Genome Analysis Shows That AAV Integrates at Chromosome 19 AAV-S1 Sites and Other Chromosomal Sites That Frequently Share GGTC Micro-Homology with the AAV P5 Promoter,"HR Drew, LJ Lockett, GW Both","Molecular Therapy 13, S47",,0,2006
853. Monitoring of Promoter-Controlled Adenoviral Replication with Noninvasive Imaging in Lung Cancer,"J Davydova, AR Nelson, T Gavrikova, LP Le, HA Ono, DT Curiel, ...","Molecular Therapy 13, S329",,0,2006
1099. RNAi-Based Therapy for the Treatment of HCV,"LB Couto, AE Parker, G Haniff, DA Suhy, AA Kolykhalov, PW Roelvink, ...","Molecular Therapy 13, S422-S423",,0,2006
374. Hepatitis Delta Virus-Mediated Amplification of Therapeutic RNAi,"D Haussecker, M Elazar, JS Glenn, MA Kay","Molecular Therapy 13, S142",,0,2006
388. Chromosomal Rearrangements in Mammalian Cells Are Induced at High Frequency by the Bacteriophage Derived Integrase phiC31,"A Ehrhardt, JA Engler, H Xu, A Cherry, MA Kay","Molecular Therapy 13, S148",,0,2006
"5. Mechanisms for Hairpin Loop Opening of “Closed” AAV-ITRs by Specific Cellular Endonuclease Activities, a Prerequisite for rAAV Vector Genome Recombinations In Vivo","K Inagaki, TA Storm, MA Kay, H Nakai","Molecular Therapy 13, S2-S3",,0,2006
Mouse Models for Human Liver Tumors,"A Tward, A Goga, K Jones, D Morgan, S Yant, M Kay, R Wang, M Bishop",Toxicologic Pathology 33 (7),,0,2005
Mesenchymal Cancer Cells Can Arise from Ex Vivo Modified Mesenchymal Stem Cells.,"J Tolar, MJ Osborn, A Panoskaltsis-Mortari, RT McElmurry, S Bell, L Xia, ...","Blood 106 (11), 4326-4326",,0,2005
In vivo selection of transplanted allogeneic hepatocytes and bone-marrow derived hepatocytes after allogeneic bone-marrow transplantation in mice,"K Streetz, R Doyonnas, D Jenkins, S Lin, J Shizuru, H Blau, K Sylvester, ...","HEPATOLOGY 42 (4), 370A-371A",,0,2005
Lessons from a clinical trial of liver-directed AAV gene transfer in hemophilia B,"J Rasko, K High, M Tigges, C Manno, D Sabatino, M Dake, M Razavi, ...","JOURNAL OF GENE MEDICINE 7 (8), 1117-1118",,0,2005
Real-time in vivo imaging transgenesis by of stem cells following transposition,"J Tolar, M Osborn, S Bell, R McElmurry, L Xia, M Riddle, ...","MOLECULAR THERAPY 12 (1), 42-48",,0,2005
87. Determinants of Toxicity Induced by In Vivo Expression of Short Hairpin RNA from AAV Vectors,"JC Giering, MA Kay","Molecular Therapy 11, 1",,0,2005
INBORN ERRORS OF METABOLISM: HEMOPHILIA,AFVF Liver-Directed,"Molecular Therapy 11, 1",,0,2005
191. Identification of a Novel Functional Domain in the Sleeping Beauty Transposase: Towards Alleviating the Restriction of SB Overproduction Inhibition,"J Park, SR Yant, MA Kay","Molecular Therapy 11 (S1), S75",,0,2005
857. A Versatile and Efficient Viral Vector Platform for Stable In Vivo Expression of Short Hairpin RNA,"D Grimm, K Pandey, KL Streetz, MA Kay","Molecular Therapy 11 (S1), S333",,0,2005
563. Differential Histone Modifications in Transcriptional Active Versus Silenced Episomal Vectors In Vivo,"E Riu, ZY Chen, MA Kay","Molecular Therapy 11 (S1), S217",,0,2005
1084. A Screen for Host Cellular Proteins That Interact with Adeno-Associated Virus Capsid Proteins,"B Akache, D Glazer, J Park, MA Kay","Molecular Therapy 11 (S1), S418",,0,2005
Evaluation of cryopreserved human hepatocytes for functional studies in vitro and in a small animal model,"KL Streetz, M Elazar, S Levenberg, MS Chua, D Wang, J Glenn, S So, ...","Zeitschrift für Gastroenterologie 43 (05), P232",,0,2005
Non-viral linear DNA vectors and methods for using the same,"M Kay, ZY Chen","US Patent App. 10/351,471",,0,2005
Direct cutaneous plasmid DNA delivery via single intradermal injection of the cis-acting Sleeping Beauty transposon system,"Z Siprashvili, JG Mikkelsen, S Yant, M Kay, P Khavari","JOURNAL OF INVESTIGATIVE DERMATOLOGY 124 (4), A87-A87",,0,2005
900. Overcoming Gender-Specific Barrier of AAV-Mediated Gene Therapy by Neonatal Intervention,"A Kume, T Ogura, H Mizukami, S Kure, T Okada, M Urabe, T Matsushita, ...","Molecular Therapy, 348-349",,0,2005
500. Biology of Novel AAV Serotype Vectors in the Liver Directed Gene Transfer to Nonhuman Primates,"G Gao, Y Lu, R Calcedo, R Grant, J Sanmiguel, L Wang, J Johnston, ...","Molecular Therapy, 194",,0,2005
573. Investigation into the Frequency of Post-Integrative Gene Silencing Using a Non-Selective Sleeping Beauty Transposition System,"BS Garrison, SR Yant, JG Mikkelsen, MA Kay","Molecular Therapy, 221",,0,2005
516. Analysis of AAV Serotype 8 Vector Integration in Normal and DNA-PKcs-Deficient Scid Mice by a Novel Strategy,"K Inagaki, X Wu, S Fuess, TA Storm, MA Kay, H Nakai","Molecular Therapy, 200",,0,2005
443. Tissue Specific Expression of Short Hairpin RNAs for the Treatment of HCV Using Liver Specific RNA Pol II Expression Cassettes,"DA Suhy, AA Kolykhalov, LB Couto, LM Garcia, AR Schroeder, AE Parker, ...","Molecular Therapy, 171-172",,0,2005
1046. Stable Correction of Hematopoietic Stem Cells with Non-Viral Gene Transfer,"M Noll, R Bennett, S Yant, MA Kay, M Grompe","Molecular Therapy, 404",,0,2005
"1000. In Vitro and In Vivo Evaluation of Optimized Short-Hairpin RNAs for the Treatment of the Hepatitis C Virus Using Expression Cassettes Producing One, Two or Three Anti HCV …","DA Suhy, LB Couto, AA Kolykhalov, AE Parker, AR Schroeder, LM Garcia, ...","Molecular Therapy, 386",,0,2005
22. Generation of Circular Sleeping Beauty DNA Transposition Substrates by RU486-Induced Flp Recombination In Vitro–Steps towards a Single Integrating Adeno-Transposon Vector,"JG Mikkelsen, SR Yant, A Ehrhardt, MA Kay","Molecular Therapy, 9",,0,2005
821. Development of a Site-Specific Integrating Gene-Deleted Adenoviral Vector for Sustained Transgene Expression Levels In Vivo,"A Ehrhardt, SR Yant, GA Jeff, H Xu, MP Calos, MA Kay","Molecular Therapy, 319",,0,2005
467. Allogeneic Bone-Marrow Transplantation in Mice Provides Tolerance and Promotes Massive In Vivo Selection of Subsequently Transplanted Hepatocytes,"KL Streetz, R Doyonnas, DD Jenkins, S Lin, JA Shizuru, H Blau, ...","Molecular Therapy, 181",,0,2005
600. A Novel Gene-Deleted Adenoviral Vector for Somatic Integration and Long-Term Phenotypic Correction of Murine and Canine Hemophilia B,"A Ehrhardt, H Xu, SR Yant, JA Engler, MA Kay","Molecular Therapy, 232",,0,2005
437. Alternative Strategies To Deliver Multiple shRNAs in Order to Simultaneously Inhibit Multiple Targets,"PW Roelvink, MW Graham, DA Suhy, LB Couto, SM Cunningham, ...","Molecular Therapy, 169-170",,0,2005
915. Adenovirus Transduction May Be Involved in the Transdifferentiation of the Liver to the Pancreas,"AY Wang, A Ehrhardt, H Xu, MA Kay","Molecular Therapy, 354",,0,2005
557. Unraveling the Molecular Mechanisms Responsible for Episomal Transgene Silencing In Vivo,"ZY Chen, CY He, H Xu, MA Kay","Molecular Therapy, 215",,0,2005
88. Driving shRNA Transcription from PolII Promoters in Mammalian Cells,"JC Giering, MA Kay","Molecular Therapy, 36",,0,2005
504. In Vivo Characterization of AAV Serotype 9 Vectors in Mice,"K Inagaki, TA Storm, S Fuess, MA Kay, H Nakai","Molecular Therapy, 195-196",,0,2005
405. Comparison Study of Structural Determinants for AAV Liver Transduction by Domain Swapping between AAV-2 and AAV-8 Capsids,"X Shen, H Xu, Z Huang, TA Storm, MA Kay","Molecular Therapy, 157",,0,2005
Transgenesis of Multipotent Adult Progenitor Cells (MAPC) with Sleeping Beauty Transposons to Determine MAPC Homing and Persistence in Real-Time In Vivo.,"J Tolar, M Osborn, S Bell, L Xia, M Riddle, A Panoskaltsis-Mortari, ...","Blood 104 (11), 2099-2099",,0,2004
A NOVEL APPROACH FOR LIVER TISSUE ENGINEERING INTO THE SUBCUTANEOUS SPACE USING HEPATOCYTE TRANSPLANTATION,"K Ohashi, JM Waugh, MD Dake, T Yokoyama, H Kuge, Y Nakajima, ...","Transplantation 78 (2), 437",,0,2004
TOWARDS ESTABLISHING A HETEROLOGOUS LIVER TISSUE USING HEPATOCYTE TRANSPLANTATION,"K Ohashi, T Yokoyama, H Kuge, H Kanehiro, M Hisanaga, S Ko, M Nagao, ...","Transplantation 78 (2), 437-438",,0,2004
Hepatic gene transfer,MA Kay,"FALK SYMPOSIUM, 171-171",,0,2004
AAV VECTORS: SEROTYPES AND APPLICATIONS AAV VECTORS: SEROTYPES AND APPLICATIONS,"H Nakai, T Storm, S Fuess, MA Kay","Molecular Therapy 9, 1",,0,2004
801. Novel Targeting Non-AAV Parvoviral Vectors for Gene Therapy,"R Itah, I Etingov, C Davis, J Tal","Molecular Therapy 9 (S1), S303",,0,2004
301. CID-Mediated In Vivo Selection: Heterogeneity Among Large Animal Models,"RE Richard, RA De Claro, S Chien, HP Kiem, T Clackson, R Andrews, ...","Molecular Therapy 9 (S1), S115",,0,2004
1001. Use of cHS4 Chromatin Insulator To Improve Efficacy and Safety of Retrovirus Vectors,"DW Emery, M Aker, T Nishino, J Tubb, G Stamatoyannopoulos","Molecular Therapy 9 (S1), S383",,0,2004
13. Hot Spots for rAAV2 Vector Integration in Mice,"H Nakai, X Wu, S Fuess, T Storm, S Burgess, M Grompe, MA Kay","Molecular Therapy 9, S6-S6",,0,2004
811. The Hotspots of Integration Targeted by the Site-Specific Integrase PhiC31 May Be Cell Line Dependent,"A Ehrhardt, JA Engler, MP Calos, MA Kay","Molecular Therapy 9 (S1), S307",,0,2004
826. Non-Viral Gene Therapy Targeting Fanconi Anemia Hematopoietic Stem Cells: A Realistic Hope?,"M Noll, R Bennett, S Yant, JG Mikkelsen, C Chen, MA Kay, M Grompe","Molecular Therapy 9, 1",,0,2004
819. Hyperactive Transposase Mutants of the Sleeping Beauty Transposon,"SR Yant, J Park, Y Huang, JG Mikkelsen, MA Kay","Molecular Therapy 9, S310-S310",,0,2004
141. Development of a one-step column purification of minicircle vector DNA devoid of bacterial sequences that results in high level persistent transgene expression in vivo,"Z Chen, C He, MA Kay","Molecular Therapy 9 (S1), S54",,0,2004
"371. Complete Inhibition of Hepatitis B Virus Gene Expression In Vivo with Short Hairpin RNA Expressed from a Novel Double-Stranded, Bi-Cistronic Adeno-Associated Virus …","D Grimm, KL Streetz, TA Storm, H Nakai, AP McCaffrey, Z Huang, ...","Molecular Therapy 9, S141-S142",,0,2004
148. The altered binding properties of sleeping beauty transposase hyperactive mutants may explain their enhanced efficacy,"J Park, SR Yant, MA Kay","Molecular Therapy 9, S57-S57",,0,2004
337. Unrestricted Liver Transduction with AAV Serotype 8 Vector in Mice,"H Nakai, T Storm, S Fuess, MA Kay","Molecular Therapy 9 (S1), S128",,0,2004
172. Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo,"AY Wang, PD Peng, A Ehrhardt, TA Storm, MA Kay","Molecular Therapy 9 (S1), S66",,0,2004
876. Towards establishing a heterologous liver in rodents,"K Ohashi, T Yokoyama, H Kuge, Y Nakajima, MA Kay","Molecular Therapy 9 (S1), S333",,0,2004
96. Transgene Expression from Recombinant AAV-8 Vectors in the Liver Occurs Independently of the Serotype Origin of the Viral Inverted Terminal Repeats,"D Grimm, H Nakai, TA Storm, EP Riu, MA Kay","Molecular Therapy 9 (S1), S38",,0,2004
1039. Mechanistic Insights into the Persistence of Non-Viral Mediated Gene Transfer In Vivo,"E Riu, Z Huang, MA Kay","Molecular Therapy 9 (S1), S398",,0,2004
58. Toward Adenoviral Mediated RNA Interference for the Treatment of Hepatitis B Virus Infection,"AP Mccaffrey, K Pandey, A Ehrhardt, Z Huang, MA Kay","Molecular Therapy 9 (S1), S24",,0,2004
308. A New Model to Functionally Measure Fusion Events in the Liver After Bone-Marrow Transplantation Over Time,"KL Streetz, DD Jenkins, MT Longaker, KG Sylvester, MA Kay","Molecular Therapy 9, S118-S118",,0,2004
815. Investigation into the Frequency of Post-Integrative Gene Silencing Using a Non-Selective Sleeping Beauty Transposition System,"BS Garrison, SR Yant, JG Mikkelsen, MA Kay","Molecular Therapy 9, S309-S309",,0,2004
Gene transfer: Bench to bedside.,MA Kay,"ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 227, U132-U132",,0,2004
362 Prevention of liver cirrhosis development in rats with recombinant SV40 vectors expressing IGF-1,"M Vera, L Martinez, M Zaratiegui, C Rodriguez, J Prieto, P Fortes","Journal of Hepatology 40, 109",,0,2004
DNA DYNAMICS AND CHROMOSOME STRUCTURE-Mutational Analysis of the N-Terminal DNA-Binding Domain of Sleeping Beauty Transposase: Critical Residues for DNA Binding and …,"SR Yant, J Park, Y Huang, JG Mikkelsen, MA Kay","Molecular and Cellular Biology 24 (20), 9239-9247",,0,2004
361 Functional measurement of fusion in the liver after bone-marrow transplantation over time,"KL Streetz, D Jenkins, G Longaker, K Sylvester, MA Kay","Journal of Hepatology 40, 109",,0,2004
PMCID: PMC2546949.,"H Nakai, A Chew, D Leonard, JF Wright, RR Lessard, JM Sommer, ...","therapy 102 (7), 2412-9",,0,2003
Hepatocyte targeting for quantifiable and functional cellular transplantation,"DD Jenkins, K Streetz, M Kay, M Longaker, K Sylvester","JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS 197 (3), S15-S15",,0,2003
402. AAV Serotype 2 Vectors Preferentially Integrate into Active Genes in Mice,"H Nakai, E Montini, S Fuess, TA Storm, M Grompe, MA Kay",Molecular Therapy 7 (5),,0,2003
NAKED DNA: METHODS,"SR Yant, B Garrison, B Daigle, MA Kay",Molecular Therapy 7 (5),,0,2003
800. Knock Down Phospholamban To Improve Heart Function by AAV-and Adenovirus-Mediated RNAi,"X Lu, Z Yuan, X Ma, X Wu, X Li",Molecular Therapy 7 (5),,0,2003
Comparison of adenovirus and adeno-associated virus for pancreatic gene delivery in vivo,"AY Wang, PD Peng, MA Kay","MOLECULAR THERAPY 7 (5), S46-S46",,0,2003
Sleeping Beauty transposase-transposon cis-vectors for efficient nonviral gene delivery and persistent gene expression in vivo,"JG Mikkelsen, SR Yant, L Meuse, Z Huang, H Xu, MA Kay","MOLECULAR THERAPY 7 (5), S74-S74",,0,2003
Determining Sleeping Beauty integration and expression efficiencies in the absence of selection,"BS Garrison, MA Kay","MOLECULAR THERAPY 7 (5), S68-S69",,0,2003
Analysis of target site selection for the Sleeping Beauty transposon in mouse liver,"SR Yant, B Garrison, B Daigle, MA Kay","MOLECULAR THERAPY 7 (5), S63-S63",,0,2003
Inhibition of hepatitis B virus by RNA interference in mice,"AP McCaffrey, H Nakai, K Pandey, Z Huang, FH Salazar, PL Marion, ...","MOLECULAR THERAPY 7 (5), S312-S313",,0,2003
218. Delivery Parameters Affecting Liver-Directed AAV Transduction,"K Ohashi, H Nakai, LB Couto, Y Nakajima, MA Kay",Molecular Therapy 7 (5),,0,2003
Cleavage/excision of plasmid DNA in vivo leads to increased maintenance and persistence of transgenes expression in mouse,"E Riu, Z Huang, MA Kay","MOLECULAR THERAPY 7 (5), S9-S10",,0,2003
"The role of gp130 in the control of the APR, liver toxicity and vector persistance after adenoviral transfer","KL Streetz, C Klein, T Wuestefeld, G Schuetz, W Mueller, MP Manns, ...","MOLECULAR THERAPY 7 (5), S148-S148",,0,2003
Australian patients in a multi-centre phase I/II trial of AAV-mediated gene transfer to the liver for severe hemophilia B,"JEJ Rasko, K High, MA Kay, B Glader, CS Manno, S Hutchinson, M Dake, ...","JOURNAL OF GENE MEDICINE 5 (5), S3-S4",,0,2003
A screen for host cellular factors that interact with the Sleeping Beauty transposase,"J Park, MA Kay","MOLECULAR THERAPY 7 (5), S72-S72",,0,2003
Development and analyses of hyperactive forms of the sleeping beauty transposase,"SR Yant, JG Mikkelsen, J Hoyt, X Hui, MA Kay","MOLECULAR THERAPY 7 (5), S9-S9",,0,2003
Evaluation of the potential of recombinant vector genomes based on serotypes of adeno-associated virus (AAV) for In vivo gene transfer,"D Grimm, TA Storm, N Hammami, M Graf, MA Kay","MOLECULAR THERAPY 7 (5), S347-S347",,0,2003
891. Simplification of AAV Pseudotype Vector Production to a Single-Plasmid Transfection After DNA Recombination (STAR) Protocol,"D Grimm, TP Quinn, AA Farmer, JA Kleinschmidt, MA Kay",Molecular Therapy 7 (5),,0,2003
AAVmediated hepatic gene transfer induces regulatory CD4+ T cells promoting tolerance to the coagulation factor IX transgene product.,"R Fraser, DG Le Couteur, A Warren, VC Cogger, P Bertolino, M Smith, ...","Blood, The Journal of the American Society of Hematology 101 (8), 3338-3338",,0,2003
DNA DYNAMICS AND CHROMOSOME STRUCTURE-Nonhomologous-End-Joining Factors Regulate DNA Repair Fidelity during Sleeping Beauty Element Transposition in Mammalian Cells,"SR Yant, MA Kay","Molecular and Cellular Biology 23 (23), 8505-8518",,0,2003
2003: we have to do better,IM Verma,"Molecular Therapy 7 (1), 1",,0,2003
Liver tissues engineered at the kidney capsule and their regeneration potential,"K Ohashi, Y Nakajima, MA Kay","CELL TRANSPLANTATION 12 (2), 150-150",,0,2003
Host chromosomal effects of recombinant adeno-associated virus vector integration in vivo.,"H Nakai, E Montini, S Fuess, TA Storm, M Grompe, MA Kay","BLOOD 100 (11), 219A-219A",,0,2002
A mechanism for free vector end removal of recombinant adeno-associated virus vector DNA in vivo.,"H Nakai, TA Storm, S Fuess, MA Kay","BLOOD 100 (11), 653A-653A",,0,2002
Transposase-based stable nonviral laminin 5 gene delivery in junctional epidermolysis bullosa,"S Ortiz-Urda, S Yant, F Scholl, Z Siprashvili, P Chen, M Kay, P Khavari","JOURNAL OF INVESTIGATIVE DERMATOLOGY 119 (1), 230-230",,0,2002
MECHANISMS OF NAKED DNA GENE TRANSFER,"H Xu, A Ehrhardt, ZY Chen, S Shen, L Meuse, MA Kay",Molecular Therapy 5 (5),,0,2002
1042. Long-T 1042. Long-Term Maintenance of Ectopically erm Maintenance of Ectopically Transplanted Hepatocytes in Mice ransplanted Hepatocytes in Mice,"K Ohashi, JM Waugh, M Dake, TT Pham, MA Kay",Molecular Therapy 5 (5),,0,2002
509. A Simple Method for Inducing RNA Interference in Adult Mice,"AP McCaffrey, L Muese, D Conklin, G Hannon, MA Kay",Molecular Therapy 5 (5),,0,2002
"ADENOVIRAL VECTORS: CHIMAERAS, INTEGRATION, PERSISTENCE","A Ehrhardt, H Xu, MA Kay",Molecular Therapy 5 (5),,0,2002
RNA VIRUS VECTORS: VECTOROLOGY,"F Park, K Ohashi, MA Kay",Molecular Therapy 5 (5),,0,2002
In vivo correction of a mouse model of hereditary tyrosinemia type I by the sleeping beauty (SB) transposon.,"E Montini, M Noll, N Morcinek, A Major, M Finegold, M Kay, M Grompe","AMERICAN JOURNAL OF HUMAN GENETICS 69 (4), 222-222",,0,2001
Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.,"J Zhang, T Hattori, A Arzumanov, AP Walsh, VK Rajwanshi, R Kumar, ...","Journal of Pharmacology and Toxicology 2 (2), 14645-14654",,0,2001
DRUG DISCOVERY AND GENOMIC TECHNOLOGIES-In Vitro Ligation-Based Cloning of Foreign DNAs into the E3 and E1 Deletion Regions for Generation of Recombinant Adenovirus Vectors,"H Mizuguchi, MA Kay, T Hayakawa","Biotechniques 30 (5), 1112-1117",,0,2001
AAV-mediated gene therapy for hemophilia B.,"K High, V Arruda, L Couto, A McClelland, M Kay, B Glader, R Herzog","FASEB JOURNAL 14 (8), A1310-A1310",,0,2000
Preclinical Vector Applications,"F Park, K Ohashi, MA Kay",Molecular Therapy 1 (5),,0,2000
A phase I trial of AAV-mediated muscle-directed gene therapy for hemophilia B.,"CS Manno, RW Herzog, VR Arruda, LB Couto, SJ Tai, A McClelland, ...","Blood 94 (10), 642A-642A",,0,1999
Optimization of factor IX gene expression in the liver of mice using cis-DNA elements.,"CH Miao, GA Patijn, L Meuse, K Ohashi, AR Thompson, MA Kay","BLOOD 94 (10), 454A-455A",,0,1999
CELL BIOLOGY AND METABOLISM-NF-kB activation is required for human endothelial survival during exposure to tumor necrosis factor-a but not to interleukin-1b or lipopolysaccharide,"K Zen, A Karsan, A Stempien-Otero, E Yee, J Tapper, X Li, T Eunson, ...","Journal of Biological Chemistry 274 (40), 28808-28815",,0,1999
Hepatocyte growth factor (HGF) induces high level hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice,"GA Patijn, A Lieber, DB Sohowalter, R Schwall, OT Terpstra, MA Kay","European Journal of Gastroenterology & Hepatology 10 (12), A58",,0,1998
Growth Regulation and Cancer-Hepatocyte Growth Factor Induces Hepatocyte Proliferation In Vivo and Allows for Efficient Retroviral-Mediated Gene Transfer in Mice,"GA Patijn, A Lieber, DB Schowalter, R Schwall, MA Kay","Hepatology 28 (3), 707-716",,0,1998
"Christopher B. Wilson, Lisa J. Embree, David Schowalter","P Linsley, MA Kay, R Albert, A Aruffo, D Hollenbaugh","J. Virol 72 (9), 7542",,0,1998
Nonviral gene transfer to the liver,"AR Thompson, MA Kay","Hepatology 24 (6), 1541-1542",,0,1996
Design and Testing of an Interference Modulator for DEW Applications.,"DK Abe, AK Mark, A Bromborsky, CJ Lazzard, R Del Rosario",ARMY RESEARCH LAB ADELPHI MD,,0,1996
DIRECT TRANSFER—VIRAL APPROACHES,M Kay,Journal of Vascular Surgery 24 (1),,0,1996
"Design and Testing of an Interference Modulator for DEW Applications(Final Report, Feb. 1995- 1996)","D ABE, A MARK, A BROMBORSKY, C LAZARD, R DEL ROSARIO",,,0,1996
ADENOVIRAL GENE-TRANSFER OF MYOD TO INJURED HEART-CARDIAC FIBROBLASTS RESIST MYOGENIC CONVERSION IN-VIVO,"CE MURRY, MA KAY, T BARTOSEK, SM SCHWARTZ","FASEB JOURNAL 9 (4), A883-A883",,0,1995
THE EFFECTS OF CONTROLLED LIVER-REGENERATION ON HEPATOCYTE TRANSPLANTATION IN THE MOUSE-IMPLICATIONS FOR EX-VIVO GENE-THERAPY,"MJ VRANCKENPEETERS, A LIEBER, J PERKINS, MA KAY","JOURNAL OF CELLULAR BIOCHEMISTRY, 386-386",,0,1995
enhance gene therapy,MA KAY,"Neuroreport 6, 369-374",,0,1995
INTRACELLULAR ANTIBODY KNOCKOUT OF THE ERBB2 ONCOPROTEIN ACHIEVES TARGETED CYTOTOXICITY OF TUMOR TARGETS BY INDUCTION OF APOPTOSIS,"J DESHANE, J GRIM, M FENG, M KAY, G SIEGAL, R ALVAREZ, ...","AIDS RESEARCH AND HUMAN RETROVIRUSES 11, S172-S172",,0,1995
Hepatic gene therapy: Efficient retroviral mediated gene transfer into rat hepatocytes in vivo,"TM Kolodka, M Finegold, MA Kay, SL Woo","Somatic Cell and Molecular Genetics 20 (3), 251-251",,0,1994
"The name of one of the authors was inadvertently omitted by the authors from the paper,"" Hepatic Gene Therapy: Efficient Retroviral Mediated Gene Transfer into Rat Hepatocytes …","MF Kolodka, MA Kay, SLC Woo","Somatic Cell and Molecular Genetics 20 (3), 251",,0,1994
DIRECT DELIVERY OF RETROVIRAL VECTORS TO CANINE HEPATOCYTES INVIVO,"MA KAY, S ROTHENBERG, W POKORNY, SLC WOO","JOURNAL OF CELLULAR BIOCHEMISTRY, 238-238",,0,1993
GENE-THERAPY FOR HEPATIC DEFICIENCIES IN ANIMAL-MODELS,"MA KAY, S ROTHENBERG, TJ LIU, W POKORNY, M FINEGOLD, ...","CLINICAL RESEARCH 40 (2), A339-A339",,0,1992
TOWARDS GENE-THERAPY FOR HEPATIC DEFICIENCIES IN A LARGE ANIMAL-MODEL,"M KAY, P BALEY, S ROTHENBERG, F LELAND, TJ LIU, W POKORNEY, ...","AMERICAN JOURNAL OF HUMAN GENETICS 49 (4), 436-436",,0,1991
TOWARDS SOMATIC GENE-THERAPY FOR PHENYLKETONURIA,"TJ LIU, MA KAY, F LELAND, G DARLINGTON, D MCDONALD, ...","AMERICAN JOURNAL OF HUMAN GENETICS 49 (4), 437-437",,0,1991
"A MOLECULAR AND GENETIC APPROACH FOR STUDYING RIBOSOMAL PROTEIN GENE REGULATION DURING DROSOPHILA DEVELOPMENT (TRANSLATIONAL MINUTE, TRANSGENIC BOBBED, MESSENGER-RNA).",MA Kay,,,0,1987
A molecular and genetic approach for studying ribosomal protein gene regulation during Drosphila development,MA Kay,Case Western Reserve University,,0,1986
RIBOSOMAL-PROTEIN GENES OF DROSOPHILA-SELECTIVE REGULATION IN DEVELOPMENT AND STRUCTURAL STUDIES,"M JACOBSLORENA, M KAY, S QIAN, H TAMATE, A RIEDL, JY ZHANG","JOURNAL OF CELLULAR BIOCHEMISTRY, 59-59",,0,1986
IMPAIRED SKELETAL MINERALIZATION IN JUVENILE X-LINKED HYPOPHOSPHATEMIC MICE-A ROLE FOR THE INTESTINE IN THE ETIOLOGY OF THE BONE-DISEASE,"RA MEYER, MA KAY, MH MEYER","CALCIFIED TISSUE INTERNATIONAL 36 (4), 495-495",,0,1984
SELECTIVE TRANSLATIONAL REGULATION OF RIBOSOMAL-PROTEIN GENES DURING OOGENESIS AND EMBRYOGENESIS OF DROSOPHILA,"MA KAY, QY JIANG, M JACOBSLORENA","JOURNAL OF CELL BIOLOGY 97 (5), A21-A21",,0,1983
PMCID: PMC2770508.,"H Xu, S Feuss, TA Storm, MA Kay",,,0,0
Directed evolution of improved AAV capsids for the ideal human liver vector--can human liver tropism and human immune evasion be achieved?,"NK Paulk, K Pekrun, L Lisowski, Y Zhang, K Chu, MA Kay",,,0,0
Design and Testing of an Interference Modulator for DEW,"DK Abe, AK Mark, A Bromborsky, CJ Lazard, R del Rosario",,,0,0
340. Silencing of Episomal Transgene Expression in Liver by Plasmid Bacterial Backbone DNA Is Associated with Histone Modifications but Independent of CpG Methylation,"E Riu, ZY Chen, CY He, H Xu, MA Kay",,,0,0
693. Adverse shRNA Cytotoxicity Can Accelerate Tumorigenesis in Genetically Predisposed Mice,"MA Kay, D Felsher",,,0,0
Gene Therapy: A Status Report,"DB SCH0WALTER, M KAY",,,0,0
RNAi induced hepatotoxicity results from loss of the first synthesized isoform of 5 miR-122 in mice 6,"YH Zhang, H Kutay, K Ghoshal, L Lisowski, MA Kay",,,0,0
Human Hepatitis Delta Virus replication by host RNA polymerase shares features with RNAi-related RNA amplification,"D Haussecker, D Cao, Y Huang, P Parameswaran, AZ Fire, MA Kay",,,0,0
High-Resolution Genome-Wide Mapping of,"SM Burgess, MA Kay, SR Yant, X Wu, Y Huang, B Garrison",,,0,0
"Hiroyuki Nakai, Clare E. Thomas, Theresa A. Storm, Sally","SP Fuess, JF Wright, MA Kay",,,0,0
